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QUILL OiN SCALPEL This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

THROMBOSIS ON PROSTHETIC
SURFACES
In this issue of the Canadian Journal
of Surgery (page 339), Foster, Smith
and Dobell review the extremely im
portant subject o f the prevention o f
clotting on prosthetic surfaces. The
problem is of importance not only for
the further development of an artificial
heart and replacements for small ves
sels and heart valves, for lessons learn
ed from a study of these surfaces may
be applicable to the prevention o f throm
bosis on viable surfaces.
Salzman,1 in a recent symposium on
“ Mechanical Surfaces and Moving
Blood” , states that it was form erly as
sumed that to be “ non-thrombogenic”
a material must be passive toward
Factor XI, the earliest step in the
intrinsic clotting system. It is now cus
tomary to view surface-induced throm
bosis as chiefly, if not exclusively, a
platelet problem— formation of a white
platelet thrombus. However, the “ red
thrombus” is the characteristic lesion
in peripheral veins, in the lung, behind
stenotic mitral valves, on the endocar
dial surface of infarcted myocardium,
and around the sewing ring o f artificial
heart valves where eddy currents and
vortices permit the accumulation of
activated procoagulant clotting factors.
In the development o f non-thrombo
genic material one must consider both
platelets and plasma coagulation; local
fluid dynamics will dictate which pre
dominates.
Everyone is familiar with the clas
sical experiment of William Hewson8
who isolated a segment of canine jug
ular vein between clamps and observed

that the blood within the vessel re
mained fluid. When poured out into a
bowl, the blood promptly clotted. More
important in the present connection
was the overlooked observation o f Hewson that the blood did not remain fluid
indefinitely, even when exposed only
to normal endothelium. Minute clots
were visible within an hour and com
plete coagulation occurred within sev
eral hours. These changes suggest that
an ideally passive surface will not be
enough to prevent thrombosis on pros
thetic surfaces.
It is now clear that a combined knowl
edge o f materials, geometry, blood flow
and the condition o f blood constituents
is needed if the thrombogenic proper
ties o f artificial organs are to be re
duced. All man-made surfaces cause
plasma to deposit a film o f protein and
to clot; most, if not all, will cause at
least some platelets to adhere, even
when clotting is prevented. Proteins
adsorb to negatively charged (anionic)
surfaces, to heparinized surfaces, to
cationic surfaces and to non-polar sur
faces. The proteins adsorb very rapidly,
in seconds, and the adsorbed film is a
preliminary step in platelet attachment,
thrombus formation, damage to red
blood cells, and possibly to leukocytes.
One of the best thromboresistant sur
faces currently available was developed
by Vincent Gott. This colloidal graph
ite-coated methyl methacrylate was
thought to inhibit blood clotting be
cause o f the smoothness of the surface.
However, the ability o f graphite to bind
heparin was discovered to be the essen
tial feature. Furthermore, it was pos
sible to bind a greater concentration o f
heparin to the surface if the graphite
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was rinsed with a cationic surface-ac
tive agent, benzalkonium chloride, be
fore exposure to heparin. Unfortunately,
this coating cannot be applied to a flex
ible surface.
What appeared at first to be a small
problem for an interested hematologist
is now the consuming occupation of
talented researchers in fluid mechanics,
surface chemistry, rheology and many
other disciplines. The problem of con
trol of thrombosis on prosthetic sur

Vol. 15

faces is patently beyond the resolving
capacity of any single discipline because
it is inextricably linked to several kinds
of phenomena, each requiring a differ
ent competence to investigate.
L. D. MacL ean
R eferences
1. Salzm an E W : Cellular reactions to surface.
Fed Proc 30: 1705, 1971
2. Gulliver G : W orks o f William Hewson,
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JAMES BELL’S APPENDICITIS
D. ALTON M URPHY, M.D., F .R .C .S JC ],* Montreal, Que.

* v

y

“ When in doubt, operate.” James Bell, 1894

(Fig. 1) was the second
Surgeon-in-Chief of the newly built
Royal Victoria Hospital in Montreal. At
the time of his death Dr. Bell was said
to be one of the most able surgeons in
America. He was known and respected
internationally. His scientific biblio
graphy of more than 100 papers dealt
with a wide variety of subjects. Ironi
cally, however, two of these articles,1' 2
which clearly defined a form of treat
ment of appendicitis, were of no avail
in altering the course of his terminal
illness.
Dr. Bell, who graduated from McGill
Medical School in 1877, was awarded
the Holmes Gold Medal for his scholastic
excellence. He was a surgical resident
at the Montreal General Hospital from
this time until 1881 when he was ap
pointed as the first Medical Superin
tendent of that hospital. This salaried
position, which carried no admitting
privileges, was devoted to forwarding
the interests of the hospital and gen
erally managing its business affairs. He
remained as Medical Superintendent
until 1885.
During this period William Osier, his
teacher and one of his friends, influ
enced him to broaden his interests. His
name appears with Osier’s on the roster
of members of the Montreal Veterinary
Association at that time. He ultimately
became President of the Montreal
Veterinary Association in 1881, a post
held by Dr. Osier several years previ
ously.3
In the spring of 1885 Dr. Roddick,
later to become Sir Thomas Roddick,
was appointed Assistant Surgeon-Gen
eral to the militia fighting in the North
West Territories against Louis Riel’s
forces.4 Dr. Bell who, up to this time,
had also been surgeon to the 6th BatJa m e s B ell

►

►k
*

p- ►
*

r *

*■

4

*Room 1130, The Montreal Children’s Hos
pital, Montreal 108, Que.

Fig. 1.—James Bell, M.D., taken around 1905.

talion, Fusiliers in Montreal joined Dr.
Roddick as the First Assistant-Surgeon
and was stationed in Swift Current,
North West Territories. Near the end
of the Rebellion,5 he ran his own mobile
field hospital unit, posted north o f Sas
katchewan Crossing.
Either he had a good press agent or
was well liked, since, during his absence
at the Rebellion, the advertisement
shown in Fig. 2 appeared in the Mont
real Gazette, Saturday, May 16, 1885,
when a consultant post became vacant
at the Montreal General Hospital.
It is unknown whether this influenced
the Governors or not, but Dr. Bell was
successful, becoming a Consultant Sur
geon at the Montreal General Hospital
in the summer of 1885. He was invited,
in 1894, to join four other surgeons on
the medical staff of the newly built
Royal Victoria Hospital (Drs. Craik,
Roddick, Buller and Gardner).6 Follow-
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piMtltauunu.
DR. JAMES BELL,
W ho Is now on M ilve nervlre In tho N»rthv»e.H',li» a cr. ml Iduto for the Surntoal vacancy
likely to occur In the staff of the Montreal
General Hospital on the 81*1 Instant, amt holn« unable personally to look after his Interest*
in tho approaching election, his friend* ear
nestly hope that Inc Governors will Rive his
application their favorable considers'lo:i It
I * hoped that l)r. Bell's lonu experience 'n
hospital work—having been resident In the
hospital for sis years—together with his wellknown aptltudo for Hurgeiy. auil his Uutermlnation to devote himself exclusively to that
branch of tho profession tnay be taken into
aooount In considering his claims, and hta
friends feel astured that his unavoidable absanoe on duty at the front will not be allowed
to Injure his prospoota of election. A short
roolar setting forth his qualification somehat more In detail, will he Issued In a day or
two, and distributed among the Governors.
Montreal, May ith, 1»8».
106

Fig. 2.—Advertisement which appeared in
the Montreal Gazette, May 16, 1885.

ing the retirement of Sir Thomas Rod
dick in 1895, Dr. Bell was appointed
Surgeon-in-Chief of the Royal Victoria
Hospital and subsequently, in 1907,
Professor of Surgery and Head of the
Department of Surgery at McGill Uni
versity.
As a man he was quiet, unobtrusive
and generally modest.7 He was above
all honest, never a bluffer, and was al
ways willing to say “ I don’t know.”
According to his wife he had three
loves: his profession, his farm and his
wife . . . in that order.8He was a slave to
work and revelled in it. After a long day
of surgery at the hospital he would
often take the electric rail car out to
his 80-acre farm on the back river and
tend his prize cattle and horses. He
called the farm Saraguay, a combination
of French-Indian for the “ path of the
raftsman” . At his death his friends
named the municipality, Saraguay, in
his honour.
In August 1894 he presented a paper
to The Canadian Medical Association
entitled “ A Year’s Expeir.ence in Ap
pendicitis” . In it he clearly spelled out
that the treatment of appendicitis was
surgical: “ . . . if recognized early and
treated surgically the mortality should
be almost nil. I am fully aware that

Vol. 15

in making these statements I am chal
lenging criticism and unfortunately
they can neither be confirmed nor re
futed by statistics for the reason that
we have no system of vital statistics in
this Country.”
He goes on to say “ . .. as for the
treatment of appendicitis, this disease
should be considered a surgical one
from the very onset. There is no medical
treatment for appendicitis. It is a local
condition which cannot be reached by
drugs and whose progress cannot be
materially modified, much less stayed,
by local application. It is in every case
a choice between an operation for radi
cal cure or palliative treatment, which
means practically leaving the patient to
his fate.” 3 “ . . . I would say, therefore,
in every case of considerable severity,
remember the danger of perforation
and operate. When perforation occurs
you will have no choice, and in most
recurrent cases, perforation will occur
sooner or later. When in doubt, operate,
and even in the later stages when it
seems almost hopeless do not be de
terred from operating.”
Remember, this was in the same sum
mer that McBurney’s famous article ap
peared, defining the incision that bears
his name.9 Actually this incision could
just as easily have been called “ Bell’s in
cision” but, in his humble description
that lacks the elaborate and attractive
geometry of McBurney’s, he says,
“ Technique— but little need be said of
the technique employed in the opera
tion. The incision was made outside the
sheath of the rectus muscle, in the line
of the fibres of external oblique, higher
or lower according to the apparent site
of the appendix, and of sufficient length
to enable the operator to complete the
operation with the greatest ease.”3
Remember, too, that such a clear out
spoken statement as to surgical plan
was not generally accepted. Many
famous surgeons presented conflicting
views as to when and on whom operation
was required. The European surgeons
favoured a conservative approach. Sir
Frederick Treves10 said it was rare to
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operate before the first five days of ill
ness and subsequently went on to
drain King Edward VII’s appendiceal
abscess in a room at Buckingham
Palace,11 thus delaying the King’s coro
nation.
It was a time when the famous sur
geon, Fowler, advocated a semi-recum
bent position for acute appendicitis
(Fowler’s position). He subsequently
went on to develop acute appendicitis
and supposedly died in this posture
from the complications of postoperative
ileus.
In all fairness it was also a time when
the diagnosis was harder to make, be
cause typhoid fever, tuberculous ileitis
and dysentery were common differen
tial diagnoses to entertain.
Despite Dr. Bell’s clear understand
ing of acute appendicitis and the best
way to treat it, it appears that he prob
ably had not convinced his colleagues.
There is some confusion as to what
happened during Dr. Bell’s terminal
illness. The records of his hospitaliza
tion have been lost. Of certainty we
know his illness lasted six to eight days
and that he died of the consequences of
unoperated appendicitis. The full autop
sy report is not available but the gross
autopsy findings are listed on a filing
card in the Institute of Pathology, Mc
Gill University. It lists the following:
appendicitis, 2 fecaliths, perforation at
base, local retrocecal abscess, pleural
effusion left chest.
He apparently took ill with a malaise
for a day or so and was in bed at his
home, 873 Dorchester Street West.
There was no nausea, vomiting or pain.
He had lost his appetite. On the third
day some of the Faculty were called in
to attend, with no conclusive diagnosis
forthcoming. Dr. Francis J. Shepherd,
Consultant Surgeon at the Montreal
General Hospital was in attendance. Dr.
Charles Martin, his physician, was out
of town. On the third day there must
have been enough concern and suffi
ciently marked abdominal findings to
necessitate the patient’s admission to
the Royal Victoria Hospital for an ex
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ploratory laparotomy. He is said to have
told his sister-in-law “ O h! they are
going to open up my belly!” 8
Joseph Wray,* who ran the first
Canadian ambulance service and a man
on whom Dr. Bell had recently operated
for appendicitis, was called to transport
him to the hospital in a horse-drawn
ambulance. Something must have al
tered the “ Attending’s” plans because
the laparotomy was never performed.
In his monograph “ The Origin and His
tory of the Montreal General Hospital”
Dr. Shepherd has written that Dr. Bell
died refusing operation. On the other
hand one of the residents, Dr. Gillis,12
states that Dr. Bell did not refuse opera
tion, and that he had an acute abdomen.
Dr. Gillis declares that he assisted at
the operation. Another report7 records
that the patient had a retrocecal gan
grenous appendix causing acute toxemia
without clear localizing signs.
One probably has to discount the re
port of the resident, since the appendix
was found at autopsy. Dr. Francis
Shepherd, who was in attendance, is so
succinct in his statements that one
wonders if he was covering for a missed
diagnosis, since it is so contrary to the
words Bell’s sister-in-law attributed to
him. One wonders if because of the pa
tient’s seniority and position that he
may have been included in the decision,
making it more difficult to follow a
clear course. The other possibility is that
because of the practice in regard to
appendiceal surgery at the time it was
hoped the signs would localize and an
“ interval” type of operation could be
performed.
On the eighth day, with his wife, son
and sister-in-law in attendance, the pa
tient died with his son’s name “ Stuart”
on his lips.
The sole purpose of this communica
tion is to recount the sad irony of Dr.
Bell’s terminal illness. Other interpreta
tions are obvious and are left to the
reader.
The author is grateful to the late Mrs. R. E.
MacDougall, and the late Dr. R. R. Gillis for
*W ray Funeral Service, a respected familybusiness in Montreal.
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their personal reminiscences. The Montreal
Gazette and the Public Archives, Ottawa were
very helpful. Dr. S. Salisbury’s help is also
appreciated.
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6. L ewis DS: Royal Victoria Hospital 188719U7, Montreal, McGill University Press,
1969
7. A rchibald E: James Bell. Surg Gynecol
Obstet 37: 93, 1923
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REVIEW ARTICLE
THROMBOSIS ON PROSTHETIC SURFACES:
A REVIEW OF ETIOLOGIC FACTORS AND PREVENTIVE MEASURES*
ERIC D. FOSTER, M.D., M A R Y R. SM ITH, M.D. and
A N T H O N Y R. C. DOBELL, M.D., Montreal, Que.
“When blood is received into a cup and is
thereby exposed, it certainly coagulates
more rapidly than when extravasated in
the cellular membrane or in the vessels:
and on the exposed surfaces it coagulates
more rapidly than anywhere else, except
around the edges of the dish in which it
is contained.”
John Hunter 1728 to 1793
B io l o g ic a l response to foreign mate
rials has come under increased study
in recent times as a result of dramatic
advances in the construction and use of
prosthetic materials. The bodily re
sponses to these materials have been as
diverse as degradation, inflammation
and thrombosis. In this context the re
sponse of blood to foreign surfaces is
of particular interest because of the
widespread use of prosthetic materials
in cardiovascular surgery. Despite in
tensive efforts by a number of investi
gators, the problem o f incompatibility
between blood and foreign surfaces re
mains unsolved.
Over two centuries ago John Hunter
recognized the effect of a foreign sur
face on the coagulation of blood. At the
present time, thrombosis on prosthetic
surfaces is an impediment to further
progress in the following areas of car
diovascular surgery: (a) prosthetic re
placements for small-diameter arteries
and venous segments, (b) prosthetic
heart-valve replacements and (c) de
velopment of a workable artificial heart.
An evaluation of patency rates for
prosthetic vascular grafts reveals a
high incidence of failure due to throm
bosis ; this is particularly prevalent with
venous replacement.1-4 Recognizing the
role of platelets in initiating graft
thrombosis, Evans and Mustard5 have
correlated characteristics of individual
patients’ platelets and duration of pro*From the Departments of Surgery and Hema
tology, Royal Victoria Hospital and McGill
University, Montreal, Que.

sthetic arterial graft patency. In spite
of careful anticoagulation, thrombus
formation on prosthetic cardiac valves
remains the most serious late complica
tion clouding the prognosis of patients
undergoing cardiac valve replacement.6,7
The development of thrombi on pros
thetic valve surface with the danger
of embolization has been discussed by
many observers.8'11 Brewer,12 reporting
on the combined statistical series of sev
eral medical centres totalling more than
1000 heart valve replacements, found
the incidence of fatal embolization to be
4% and non-fatal embolization 8% postoperatively. An artificial heart for hu
man application awaits development o f
a satisfactory non-thrombogenic ma
terial. In addition to its non-thrombogenic characteristic, the material called
for by most artificial heart designs
must be flexible.13,14
T h r o m b u s F o r m a t io n
P r o s t h e t ic S u r f a c e

on a

Virchow first suggested the im
portant triad of factors leading to
thrombosis: (1) hypercoagulable blood
factors, (2) stasis of flow, and (3) loss
of the normal vascular lining.
By itself any one of these factors will
not produce thrombosis generally; how
ever, a combination of any two factors
will lead to thrombus formation. Con
sidering this triad, it is not surprising
that thrombosis occurs on prosthetic
material introduced into the blood
stream. The surgical procedure to in
stall the prosthetic device can produce
hypercoagulable blood factors; despite
advances in design to streamline flow
through a prosthesis, there remains
some stasis in most artificial devices;
and prosthetic surfaces at present are
“ foreign” when compared to the normal
vascular lining. In addition to the three
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Fig. 1.—Simplified diagram showing current concepts of blood coagulation.

factors suggested by Virchow, tur tor converts prothrombin to thrombin
bulence is recognized now as important which, in turn, converts fibrinogen to
in initiating and propagating prosthetic fibrin. Fig. 2 summarizes these clotting
events on a polymer surface in relation
thrombosis.
Although progress in prevention of to the duration of blood-surface contact.
clotting on prosthetic surfaces has been While most prosthetic thrombosis is
limited, knowledge of the various stages generated through mechanisms of the
of clot formation has expanded rapid “ right-hand pathway” (Fig. 1), the
ly.1517 Fig. 1 shows the current concepts “ left-hand pathway” undoubtedly con
o f blood coagulation as described by tributes to the production of thrombus,
Marcus.18 The “ right-hand pathway” is particularly that occurring at the pros
the mechanism for clotting that prob thetic-endothelial junction where trau
ably occurs on an intravascular prosthe ma produces sufficient “ tissue factor”
tic surface; the “ left-hand pathway” de to activate the extrinsic system.21
scribes the formation of a thrombus in
E t io l o g ic F a c t o r s
an area of tissue injury. Blood-coagula
In an attempt to find the causes of
tion studies on foreign surfaces have
been carried out under direct observa prosthetic thrombosis, investigators
tion in static conditions using glass test
A
tubes, and in a flowing state using ex
tracorporeal shunts.19,20 With blood-pro
sthetic surface contact, clotting seems
to be initiated by the immediate adsorp
tion of Hageman protein (Factor XII)
on the foreign surface with activation
of this factor. Activated Hageman pro
tein, in turn, activates plasma thrombo
plastin antecedent (Factor X I) ; with a
cascading effect there is rapid activa
m
tion of the other clotting proteins and
the generation of intrinsic prothrombin
Fig. 2.—A scheme for thrombogenesis on
activator. Intrinsic prothrombin activa polymer surfaces.
POLYMER
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have studied the physical properties of
the prosthetic surfaces and compared
them to the physical properties of the
normal vascular lining.
The following physical properties
have been of particular interest: (a)
smoothness, (b) wettability, (c) elec
trical charge, and (d) zeta potential.
Smoothness of the vascular intima was
considered important in preventing in
travascular clotting; however, there are
numerous reports of thrombosis of
smooth vascular grafts.5, 22, 23 Dreyer,
Akutsu and K olff23 found that a rough
prosthetic surface seemed to be an ad
vantage because it soon acquired a fib
rinous covering which evolved into a
smooth layer resembling the endothe
lium. The roughness of a prosthetic sur
face becomes important if it produces
turbulence in blood flow across it. The
vascular wall is hydrophilic, thus it
would seem that the ideal prosthetic in
travascular material would be hydro
philic also.24 However, many of the best
thromboresistant surfaces produced
thus far, such as siliconized glass and
polyvinyl pyrrolidone surfaces, are hy
drophobic. Vroman17,25 has studied ad
sorption of various clotting proteins on
hydrophobic and hydrophilic surfaces:
Factors XI, VIII, V and thrombin and
fibrinogen are hydrophobic proteins
and would be readily adsorbed by hydrophobic materials; Factors XII, IX, X
and prothrombin and fibrin tend to be
hydrophilic proteins adsorbed by hydro
philic surfaces. In 1927 Abramson28 de
monstrated that all blood cells are neg
atively charged at the pH of blood and
move toward the positive pole in an
electrophoretic cell. Sawyer and Pate,27
in 1953, demonstrated a similar neg
ative charge on the blood vessel wall;
they found that the undamaged intima
of the aorta is normally negative with
respect to the adventitia with a poten
tial difference in the range of -1 to -5
millivolts, and with trauma to the in
tima this polarity is reversed. Most
polymers have a negative charge on
their surfaces ranging from -8 to -25
millivolts in the presence of a flowing
saline solution. In the past, many work
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ers thought to develop a non-thrombogenic surface with polymers because of
the mutually repulsive charges on the
polymer surface and the platelets, red
blood cells and leukocytes. However,
with most negatively charged polymers
the surface charge quickly approaches
zero as plasma is passed over it; this is
most likely owing to the rapid adsorp
tion of plasma proteins on to these sur
faces.28 Nevertheless, thrombosis is in
hibited by an electronegative field.29,30
Work continues to develop a thrombo
resistant surface that will either re
tain its negative charge after being ex
posed to plasma, or a surface that will
develop a negative charge after contact
with blood.31 The zeta potential, an electrokinetic phenomenon, involves relative
motion between a charged surface and
a bulk solution. When the solid surface
is stationary as with the intima, the
potential induced by the flow of blood
is called a streaming potential. Strictly
speaking it is not a phase-boundary po
tential because it is developed wholly
within the fluid region. The plane of
slip lies between the double layer of
ions adsorbed on the surface and the
fluid medium. The zeta potential is
highly negative in thromboresistant
surfaces but depends on the electric
charge on the prosthetic surface. There
fore, with most polymer surfaces, the
zeta potential approaches zero rapidly
with exposure to blood, secondary to the
deposition o f protein on the plastic sur
face.28
In reviewing the findings of many in
vestigators concerning the importance
of various physical properties of pros
thetic surfaces and their thromboresistance, it is clear there are divergent
views. Duplication o f the normql vas
cular lining is far from possible. In fact,
none of the usually measured physical
characteristics of prosthetic surfaces
such as smoothness, wettability, electric
charge and zeta potential may have a
direct influence upon its compatibility
with blood.32 At present the chemical
nature of the surface appears to be of
overriding importance.
An important chemical property of
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normal vascular endothelium is that
it contains an anticoagulant acid muco
polysaccharide. Many research workers
have attempted to duplicate this chem
ical feature in their search for a nonthrombogenic surface. The ground sub
stance and tissue mast cells of vascular
endothelium are rich in acid mucopoly
saccharides ; specific components in
clude chondroitin sulfates A and B, hya
luronic acid and heparitin sulfate.33'35 It
has been shown that the mucopolysac
charide extract of human aorta, 0.5%
by weight, displays anticoagulant prop
erties which can be neutralized with
protamine sulfate. The active mucopoly
saccharide has been identified as chon
droitin sulfate B.33 McGovern36 demon
strated in vivo the surface anticoagulant
effect of endothelial ground substance
as it spread out over injured endothe
lium after trauma. To date, one of the
most successful non-thrombogenic sur
faces is the graphite-benzalkonium
chloride-heparin (GBH) surface de
veloped by Gott, Whiffen and Dutton.37
Heparin, an acid mucopolysaccharide, is
a close chemical relative to chondroitin
sulfate B.
While we lack knowledge about the
precise physicochemical process that
initiates clotting of blood on a prosthe
tic surface, there is considerable his
tologic evidence concerning the type of
thrombus formed. The initial lesion that
develops on prosthetic devices is the
“ white-thrombus” , which consists main
ly of platelets, strands of fibrin and oc
casional leukocytes. If the platelet mass
enlarges to the point where it becomes
occlusive and stasis develops then the
“ red thrombus” may develop behind the
platelet mass; it is composed of erythro
cytes, leukocytes, fibrin and platelets
distributed in a random fashion. White
thrombi are seen in high-blood-flow
states while red thrombi are found
primarily in static, low-blood-flow
states. Several groups of investigators,
who studied the formation of thrombi
in plastic extracorporeal shunt systems,
found that the platelet is the earliest
and only invariable component of these
thrombi.19,20

Vol. 15

R ole of t h e P latelet in
P rosthetic T hrombosis

The interaction of platelets with pros
thetic surfaces is one of the most im
portant stimuli in the initiation of
thrombosis.38, 39 In vivo platelets exist
as non-nucleated disc-shaped “ cells” , 2/x
to 3/tx in diameter surrounded by blood
plasma. Although Bizzozero,40 in 1882,
recognized the role platelets played in
thrombus formation, more detailed
studies of platelet function could not
be made until introduction of the elec
tron microscope. These tiny formed ele
ments may alter their size, shape and
biochemical composition in response to
environmental changes. At present
there seem to be three distinct stages in
the platelet response to a prosthetic sur
face leading to the platelet mass or
white thrombus formation. These are:
(a) adherence of platelets to the sur
face leading to release of platelet con
stituents, (b) aggregation of platelets
induced by adenosine diphosphate
(AD P), and (c) thrombin production
causing further platelet aggregation,
release of platelet constituents, and
fibrin formation around the periphery
of the platelet mass.5
It remains unclear how a prosthetic
surface differs from the normal vas
cular lining thereby stimulating cir
culating platelets to adhere to it, but the
stimulating factor is probably chemical
rather than a physical property of the
prosthetic surface. One theory for the
triggering of platelet adhesion to pros
thetic surfaces holds that the platelet’s
plasma membrane contains a phospholipoprotein which is readily adsorbed by
most plastic surfaces. Once the surface
has adsorbed the phospholipoprotein,
Hageman protein can be adsorbed and
activated, leading to activation of the
intrinsic system and platelet adhesion.1
Another explanation is based on the fact
that some 15 platelet proteins have been
identified including coagulation Factors
V, X, XIII, and Hageman protein ad
sorbed on the plasma membrane.18 Ad
sorption of these platelet proteins on to
the prosthetic surface may lead to their
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activation and platelet adhesion. Ad
herence of platelets to the prosthetic
surface leads to release of their consti
tuents— serotonin, histamine and ade
nine nucleotides (ATP and A D P ).15
When platelets are exposed to ADP
they change from their characteristic
disc shape to a more rounded form with
pseudopods, and they adhere to one an
other— a phenomenon termed “ platelet
aggregation” .41 This ADP-induced ag
gregation of platelets on to the prosthe
tic surface depends upon the presence
o f calcium ions, and metabolic energy
is involved.42,43 Initially, the principal
source of ADP is thought to be that re
leased from platelets adhering to the
prosthetic surface; however, erythro
cytes have a high content of ADP and
many contribute to the total amount
available if significant hemolysis is
present.44 ADP-platelet aggregation is a
reversible process: following deaggre
gation they quickly return to their ori
ginal disc shape.15 The extent of aggre
gation and the stability of the platelet
aggregates are related to the amount of
ADP available and the speed at which
it is dephosphorylated. Once ADP is lost
from the fluid surrounding the platelets,
they deaggregate unless fibrin is
formed to stabilize the mass.45
With activation of the “ water fall”
sequence of the intrinsic coagulation
system (Figs. 1 and 2), thrombin is
rapidly formed in the area of the plate
let aggregates at a rate faster than it
can be diluted by flowing blood and neu
tralized.15 Platelet membrane phospholipoprotein functions at two stages in the
development of intrinsic prothrombin
activator to which it supplies a catalytic
surface for the interaction of the plas
ma coagulation factors (Fig. I ).46' 47 This
platelet contribution to the coagulation
process is known as “ platelet-factor 3”
(P F -3 ): in vivo, this activity appears
before the formation of thrombin and
originates from the plasma membrane
of aggregated platelets. Thrombin pro
duces two distinct phenomena in throm
bus formation: (a) the further aggre
gation of platelets and release of their
constituents, and (b) conversion of fib 
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rinogen to fibrin. In the presence of
thrombin the entire platelet aggregate
contracts, an effect probably mediated
by the contractile platelet protein,
thrombostenin.48 The aggregation of
platelets with release of their constitu
ents and the contraction of the platelet
aggregate in response to thrombin ap
pear to be irreversible: it is a part of
the platelet mass development stage
known as “ viscous metamorphosis”
where the platelets lose their individual
identity because there is breakdown of
plasma membranes and a coalescing of
all platelet components.40 Thrombin
causes the conversion of fibrinogen to
fibrin and activates the fibrin-stabil
izing factor, Factor X III.50 Electron mi
crography has shown that the fibrin is
laid down initially around the periphe
ry of the platelet mass, stabilizing it.51
As depicted in Fig. 2, this series of
platelet events in the formation o f a
white thrombus on a prosthetic surface
takes place over a short period; the first
platelets adhere to a foreign surface
within one minute of exposure to blood,
by one hour the thrombus is composed
of aggregated platelets surrounded by
fibrin, and at one day the thrombus is
a mass of fibrin with platelet debris
interspersed among the fibrin fibres.15
However, it must be kept in mind that
the amount of thrombus formation is
highly variable; it depends not only
upon the thrombogenicity of the pros
thetic surface, but upon the degree of
each individual’s coagulation response.
I nhibition of P latelet A dhesion
A ggregation

and

A large number of compounds inhibit
platelet adhesion-aggregation. Although
many have proved effective in vitro
they cannot be used in vivo because o f
toxic side effects.16' 52, 53 Table I provides
a summary of some of the compounds
that have demonstrated platelet inhibi
tion and might be used in vivo. All of
the substances listed are thought to be
capable of depressing both platelet ag
gregation by ADP and the release of
platelet constituents, except the imipra-
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TABLE I.— P latelet I nhibiting C ompounds

Vol. 15-

Methyl xanthines inhibit phosphodies
terase, an enzyme that normally breaks
Compound, group
Examples
down platelet cyclic A M P: diminution
in platelet cyclic AMP is associated
Adenine compounds
ATP, AM P, adenosine,
with
platelet aggregation.59 Of the
2-chIoroadenosine
Antihistamines
chlorpheniramine
monoamine oxidase inhibitors, niala
Fibrinogen degradation
mide has been demonstrated to inhibit
products
“ early” F D P
platelets when given to humans in doses
“ late” FD P
Imipramine compounds imipramine hydrochloride
of about 3 mg,/kg. body weight.52 Non
Methyl xanthines
caffeine, theobromine
steroidal
anti-inflammatory drugs in
aminophylline
Monoamine oxidase
clude acetylsalicylic acid and the pyra
inhibitors
nialamide
zole drugs; these compounds have been
Non-steroidal anti-in
studied intensively by Packham et aZ.60'62
flammatory drugs
acetylsalicylic acid
Prostaglandins
prostaglandin Ej
who have demonstrated that these sub
Pyrazole drugs
sulfinpyrazone
stances inhibit the platelet release reac
phenylbutazone
Pyrimido-pyrimidine
tion. Prostaglandin E is the most potent
dipyridamole
compounds
RA233*
inhibitor of platelet aggregation in
RA433f
vitro, but its use in vivo may be limited
because of its vasodilator effect.63 Of
*2, 6-bis(diethylamino)-4-piperidino-pyrimido-(5, 4the pyrimido-pyrimidine compounds,
d) pyrimidine.
f2, 4, 6-trimorpholino-pyrimido-(5, 4-d) pyrimidine.
dipyridamole has undergone the most
study. It inhibits ADP-induced platelet
mine compounds, non-steroidal anti-in aggregation and the platelet release re
flammatory drugs, and the pyrazole action, as well as promoting deaggrega
drugs which do not inhibit ADP-in- tion of human platelets in vitro.64 En
duced platelet aggregation. Many of couraging clinical results have been re
these compounds have, as a common ported with the use of dipyridamole in
denominator, the capacity of vasodila preventing thromboembolic complica
tion : for example, adenine compounds, tions among patients after cardiac valve
prostaglandins
and
pyrimido-pyri replacement.65 Dipyridamole and two
midine compounds.54 The role played by related compounds, RA233 and RA433,
vasodilation, if any, in platelet inhibi are potent vasodilators in addition to
tion continues under study. Of the ade being platelet inhibitors. Of the three,
nine compounds, adenosine and 2-chlo- RA433 seems to produce the greatest
roadenosine have proved effective in platelet inhibition per milligram with
inhibiting ADP aggregation and plate the least vasodilation.66
Although there are contradictory re
let release reactions. However, both are
strong vasodilators and may have a ports concerning the effect of anti
hypotensive effect in vivo,55 Antihista coagulants on platelet function, these
mines decrease platelet adhesiveness substances probably have little direct
and. in higher concentrations, inhibit effect on platelet adhesion, aggregation
the release reaction.56 Fibrinogen degra and the release reaction. Oral anticoa
dation products (FD P), particularly the gulants such as dicoumarol do not affect
“ early” FDP fraction, interfere with platelet adhesiveness as judged by in
platelet aggregation by ADP and throm vivo animal tests; with extracorporeal
bin, inhibit the release reaction and de shunts, platelet thrombi could not be
crease platelet adhesiveness to glass.57 prevented even when doses of dicouma
The imipramine compounds are consi rol were used sufficient to prolong the
dered to be “ membrane stabilizer” prothrombin time to over 60 seconds.67
drugs when functioning as platelet in Heparin combines reversibly with Fac
hibitors; they will block the release of tor IX, preventing further progress of
platelet constituents including ADP, but the “ water fall” coagulation sequence
have no effect on the aggregating ac (Fig. 1 ): it blocks prothrombin activa
tion of circulating ADP on platelets.58 tion preventing the formation of throm-
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bin.68 Thus heparin’s action on platelet
function is indirect; it acts by reducing
thrombin activity. High doses of hepa
rin, much above those conventionally
used for an anticoagulant effect, can in
hibit platelet response to ADP.69

345

polyvinyl pyrrolidone and silicone rub
ber, that showed resistance to throm
bosis significantly greater than that of
siliconized glass.
One of the most important findings in
the search for a thromboresistant sur
face was made in 1961 when Gott et al.
76 found that a methyl methacrylate sur
R eview of N o n - throm bogenic
face coated with colloidal graohite was
S urfaces
highly resistant to thrombus formation
Freund, in 1903, observed that coat in vivo. Initially it was believed that
ing of glassware with vaseline pro this surface’s smoothness and inertness
longed the clotting time of blood; this inhibited blood clotting. However, it
is believed to be the earliest report of was demonstrated that graphite’s most
an attempt to modify a foreign surface important anticoagulant property was
in contact with blood. In the same year, the ability to bond heparin to its sur
Bordet and Gengou70 found that the face. Subsequent work by Gott showed
clotting time could be prolonged by coat that a higher surface concentration of
ing glass with paraffin. The next major heparin could be obtained if the gra
event in thromboresistant-surface re phite was rinsed with a cationic sur
search came in 1930 when Lampert71 face-active agent, benzalkonium chlo
stated that the ability of a surface to ride, before exposure to heparin.37 The
delay the coagulation of blood was pro result of this work was the “ GBH sur
portional to the capacity of that surface face” , or graphite-benzalkonium-hepato repel water (Lampert’s Rule). Sur rin surface. By incorporating heparin
face wettability underwent further stu this surface has an acid mucopolysac
dy and, in 1949, Donovan and Zimmer- charide similar to that found in the
mann72 expressed the view that water normal intima. Present evidence in
repellence was a major, but not the sole, dicates that the thromboresistance of
factor in the ability of a surface to pre GBH surfaces is owing to the fact that
vent clotting. In 1951 a surface of poly a heparinized surface has the ability to
styrene sodium sulfonate was prepared bond both unactivated and activated
in an effort to simulate the polysac Hageman factor tightly so that the lat
charides of the intima; it was found ter substance cannot be released in com
that this surface markedly prolonged bination with Factor XI (PTA) (Fig.
in vitro clotting times and its negative 1) and thus initiate the “ water fall”
charge was believed to be of prime im clotting sequence with eventual conver
portance.73 As has been stated, present sion of fibrinogen to fibrin.77 It*is of
research indicates that surface wet interest to note that the GBH surface is
tability and electric charge have little moderately wettable and has a negative
influence on determining blood com surface potential, even after exposure to
blood, two more similarities with nor
patibility.32
The search for a non-thrombogenic mal intima. Good stability of a GBH
surface gained impetus following the surface in vivo has been demonstrated
development in 1953 by Hufnagel and using 35S heparin; 20% of the original
Harvey of a prosthetic aortic valve activity was present after three months
made of plexiglass. Interest in silicon of exposure to the blood stream.78 Of
ized surfaces arose following reports in further interest is that GBH surfaces
1954 that siliconized glass was the best will retain their clot-repellent ability
material for delaying the clotting of in vivo despite intravascular infusions
blood.74 In 1961 Ross et al.7i reported on of protamine sulfate.79 Clinically, GBHtheir evaluation of the thromboresistant coated shunts have been used successful
properties of 30 commercially available ly for aortic bypass in the elective re
polymers; they found several, such as section of descending thoracic aortic
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aneurysms.80 As promising as the GBH
surface appears, it has one important
shortcoming, namely, it cannot be ap
plied to flexible surfaces because of the
graphite.
At the present time many of the nonthrombogenic materials being developed
by investigators throughout North
America are sent to Dr. V. L. Gott at
the Johns Hopkins Medical Center for
evaluation. Dr. Gott has undertaken
this task in conjunction with the Na
tional Heart and Lung Institute in the
United States. The following analysis
of non-thrombogenic surfaces is based
on Dr. Gott’s progress reports to the
N.H.L.I.81 The materials evaluated can
be classified into three groups: (a)
heparinized surfaces, (b) surfaces with
ionic radicals or imposed electrical
charges and (c) surfaces of relatively
inert materials. Figs. 3 to 5 provide
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Fig. 3.—Heparinized surfaces
evaluation for thromboresistance.

undergoing

examples of each of these three groups.
The goal of those seeking to develop a
heparinized surface is to achieve all the
favourable points of the GBH surface
but, additionally, to have flexibility. De
spite mounting evidence to the con
trary, many investigators continue to
seek to develop a thromboresistant sur
face by imparting to it an electrical
charge. The degree of the thrombore
sistance seen with these charged sur
faces probably depends more upon
the chemical nature of the surface.
Developers of inert materials seek to
achieve blood compatibility by creating
a surface that will not activate the clot
ting proteins of the intrinsic coagula
tion system. Some favourable results
have been found with in vivo tests of
these materials, particularly those in
groups (a) and (c). A favourable factor
concerning the heparinized surfaces is
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Fig. 4.—Surfaces with ionic radicals or im
posed electrical charges.

that they seem to have more initial
thromboresistance. However, unfavour
able factors are that heparin can gradu
ally be depleted from the surfaces and
heparinized materials seem to bind
large quantities of lipid which can
structurally weaken many surfaces. A
favourable factor concerning the nonheparinized materials, groups (b) and
(c), is that they may have a more stable
surface over long periods of implanta
tion. Unfavourable factors are that
hydrated and protein-coated surfaces
cannot dry out during insertion of the
prosthesis and some of these coatings
are difficult to bond to underlying ma
terials.
Bernhard et al,82and others83sought to
develop biologic thromboresistant ma
terials by enhancing pseudoendothelialization on surfaces of intravascular
prosthetic devices by seeding them with
fetal fibroblasts grown in tissue cul
tures. With a covering of pseudoendo
thelium, prosthetic materials can no
longer activate blood coagulation facRESEARCH GROUPS
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Fig. 5.—Surfaces of relatively inert mate
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tors by contact mechanisms. In animal
experiments with polyurethane surfaces
flocked with Dacron fibrils and seeded
with bovine fetal fibroblasts, pseudoendothelialization on these surfaces in
creased compared with control materials
when used in large calibre arterial
grafts, ventricular assist devices and to
tal artificial hearts.84However, complete
pseudoendothelialization of a surface
may take days, even with a fibroblastimpregnated material, necessitating sys
temic anticoagulation immediately fol
lowing implantation of the fibroblastcoated device. The possibility of immu
nologic rejection of allogenic fibroblasts
must be evaluated also.
Despite the efforts of many workers,
a totally satisfactory non-thrombogenic
material that is durable and flexible has
not yet been developed.
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R esum e
La thrombose declenchee par une prothese
intravasculaire demeure une des grandes com
plications de la chirurgie cardiovasculaire. Les
mecanismes de la coagulation, tels qu’on les
connait actuellement, sont rappeles avec atten
tion, notamment ceux qui concernent la forma- •
tion et la propagation des thrombus sur la sur
face des protheses. Les auteurs soulignent le
role des plaquettes dans la thrombogenese,
rappellent la fonction des plaquettes et discutent les merites des agents antiplaquettaires
connus. Ils brossent un bref historique des tentatives faites pour modifier les surfaces des
protheses artificielles, en vue de prevenir la
thrombose. Malgre les enormes efforts de nombreux chercheurs, la surface athrombogene
ideale reste encore a decouvrir.
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TRAUMATIC RUPTURE OF THE THORACIC AORTA*
S. R. K R ISH N A IYE N G A R , M.B., B.S., F.R .C .S.[C ], E D W A R D J. P. CHARRETTE,
M.D., F .R .C .S.[C ], F.A.C.S., R. B EV E R LE Y L Y N N , M.D., F.R.C.S.(Eng. & Edin.),
F.A.C.S. and RICHARD M cA R IH U R , M.D., F .R .C .S.(E din .), K ingston, Ont.

On reviewing 194 patients with automo
bile chest injuries, Molnar and Face1
found that 25% sustained major in
juries of intrathoracic organs and 3.5%
had rupture of the thoracic aorta. For
this reason the surgeon should suspect
traumatic rupture of the aorta in all
patients with blunt chest trauma.
About 80% of patients with trauma
tic aortic rupture die of massive hemor
rhage before reaching a hospital.2 Of
the remaining 20%, four-fifths live for
a few hours to three weeks before fatal
bleeding occurs. Finally, of such pa
tients, one in 20 who have no evidence
of aortic injury at the time of accident
develops an aortic aneurysm months or
years later.
Recent diagnostic and technical ad
vances have made it possible to salvage
•From the Division of Cardiovascular and
Thoracic Surgery, Queen’s University, King
ston, Ont.

some of the patients who survive for a
few hours or longer, if the lesion is
diagnosed and accurately located angiographically and the patient is taken to
the operating room at once.
This paper describes our experience
with seven patients with traumatic rup
ture of the thoracic aorta. These cases
illustrate some salient features of the
pathophysiology, natural history, clini
cal presentation and surgical manage
ment of this condition.
C a s e R eports

Case 1.— J.T., a 28-year-old white man,
was admitted to the Kingston General Hos
pital on August 30, 1967 with the com
plaint of “bursts” of sharp pain in his right
subcostal region. Ten years earlier he had
sustained multiple injuries, including chestwall and lung contusion, in an automobile
accident and had been unconscious for a
month. His blood pressure was 138/66 mm.

Fig. la
Fig. lb
Fig. 1.—Case 1. (a) Posteroanterior radiograph showing widened aortic arch with a rim
of calcium, (b) Transbrachial aortogram showing saccular aneurysm distal to the left sub
clavian artery.
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Hg in the right arm and 124/64 in the left
arm, his pulse was 80/min. and regular,
and he had a grade 1 to 2 systolic ejection
murmur loudest at the second left inter
costal space. All the peripheral pulses were
normal. The chest radiograph showed un
folding of the ascending aorta and widening
of the arch with a rim of calcium (Fig. la ).
An aortic arch angiogram showed a sac
cular aneurysm distal to the left subclavian
artery (Fig. lb ). When a left thoracotomy
was performed on November 1, 1967 we
found a saccular aneurysm with a broad
base. The wall was heavily calcified and
since there were no detectable areas of
weakening prone to rupture, the planned
resection was abandoned. The patient re
mains well five years later.
Case 2.— L.S., a 75-year-old white woman,
was admitted at 5:30 p.m. on July 20, 1970
with multiple injuries sustained in a motor
vehicle accident. She was alert and con
scious but complained of lancinating pain
in the back. There was paradoxical motion
of the left chest and she was tender in the
parascapular area. There was diminished
air entry over the whole left lung field with
the presence of moist rales. The left second
to seventh ribs were fractured. A poorly
defined shadow over the left lung field sug
gested either lung contusion or hemothorax
(Fig. 2a). Her pulse was 80/min. and her
blood pressure was 135/80 mm. Hg. Intra-
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Fig. 2.—Case 2. (a) Pulmonary contusion or
left hemothorax— 6 :0 0 p.m. July 20, 1970.
(b) Possible widening of the superior media
stinum in addition to left hemothorax — 8:00
p.m. the same day. (c) Further mediastinal
widening 20 minutes later. This was followed
immediately by sudden drainage of a large
volume of blood through the intercostal tubes,
and death.
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inserted into appropriate intercostal spaces
and 200 ml. of blood was evacuated from the
pleural cavity. Her vital signs remained
stable. At 8:00 p.m. another supine portable
chest film (Fig. 2b) showed possible widen
ing of the superior mediastinum and this
increased markedly over the next 20 min
utes (Fig. 2c). At that time 1000 ml. of
blood suddenly drained from the chest
tubes and the patient went into shock. In
spite of rapid blood transfusions she died
within a few minutes. Autopsy showed a
transverse tear of the aortic isthmus distal
to the left subclavian artery (Fig. 3).

Fig. 3.—Case 2. Transverse tear of the aorta
(1) distal to the left subclavian artery (2). A
periaortic hematoma can be seen through the
tear.

venous fluids were started and an endo
tracheal tube was inserted to assist respira
tion with a Bennett respirator. Apical
anterior and posterolateral chest tubes were

Case 3.— N.M., a 22-year-old student
nurse, sustained craniocerebral injuries,
pulmonary contusion, multiple lacerations
and a fracture of the left olecranon in an
automobile accident in August 1967. Treat
ment included tracheostomy and controlled
ventilation. The fracture required internal
fixation. She recovered and was discharged
on August 25, 1967. Three months later she
felt something “ snap” in her chest while
playing basketball. A chest film at this
time showed a change in the contour and
prominence of the aortic arch (Fig. 4).
An aortogram demonstrated an aneurysm
of the thoracic aorta distal to the left sub
clavian artery (Fig. 5). On January 25,
1968, at left thoracotomy, an hourglass-

Fig. 4a
Fig. 4.—Case 3. Posteroanterior chest roentgenograms
bulging aortic arch three months after injury.

(a)

Fig. 4b
normal before injury,

(b)

November 1972

RUPTURE OF THORACIC AORTA

353

Fig. 6.—Case 4. Large superior mediastinal
mass displacing the trachea to the right.
operative period. He remains completely
asymptomatic four years later.
Fig. 5.—Case 3. Aortogram showing a false
aneurysm at the aortic isthmus.
shaped false aneurysm five inches in length
was found just distal to the left subclavian
artery. There was almost total transection
of the aortic wall necessitating the insertion
of a tubular Dacron graft using femorofemoral partial bypass. She recovered un
eventfully and remains well more than five
years later.
Case U-— F.S., a 26-year-old white man,
was admitted to the Kingston General Hos
pital emergency department on November
15, 1968 after an automobile accident. He
was conscious but somewhat disoriented.
Except for a laceration of the left ear, there
were no signs of external injury. His pulse
was 80/min. and regular, and his blood
pressure was 160/80 mm. Hg. On physical
examination the findings were within nor
mal limits. A chest film showed a large
mediastinal mass which displaced the
trachea to the right (Fig. 6). An aortic
arch angiogram showed a tear of the
thoracic aorta d'stal to the left subclavian
artery (Fig. 7). Under femorofemoral par
tial bypass we resected the false aneurysm
and restored the continuity of the aorta
with an interposed Teflon graft. The pa
tient required tracheostomy and ventilatory
support because of bilateral pulmonary
contusion which became evident in the post-

Case 5.— C.D., a 48-year-old man, sus
tained multiple injuries in an automobile
accident on July 15, 1970. He was seen in
an outlying hospital in a state o f shock
from chest and intra-abdominal injuries
and a comminuted fracture of the left
femur. Chest radiograph showed a widened

Fig. 7.—Case 4. Aortogram showing a peria
ortic hematoma in the region of the tear.
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mediastinum and fracture of ribs on the
left side. After resuscitation he was trans
ferred to the Kingston General Hospital
and, on arrival, his blood pressure was
stable and his pulse was 80/min. On aortic
arch angiography the dye extravasated
distal to the left subclavian artery. He had
abdominal rigidity and rebound tenderness
and on the angiograms his spleen was dis
placed suggesting splenic rupture.
A laparotomy was carried out first. The
ruptured spleen was removed and hemor
rhage from a tear in the mesentery was
controlled. After this operation was com
pleted he was placed on femorofemoral
partial bypass and a left thoracotomy per
formed. The aortic tear involved one-half of
its circumference just distal to the sub
clavian artery. It was possible to approxi
mate the divided edges of the aorta so that
a prosthetic graft was not required.
His postoperative course was stormy be
cause he had a number of complications
involving several organ systems. His flail
chest required tracheostomy and assisted
ventilation for four weeks. He developed a
severe pneumonia which responded to spe
cific antibiotic therapy. Because he had
some degree of dysphagia, nasogastric tube
feeding was started. In the third week he
developed massive upper gastrointestinal
bleeding which responded to blood transfu
sion and antacid medications. When oral
feedings were attempted we found he had
paralysis of the muscles of deglutition and
also bilateral vocal cord paresis. The naso
gastric tube was reinserted and tube feed
ings were reinstituted. Despite the tra
cheostomy, gastroesophageal reflux and
aspiration occurred owing to incompetence
of the esophageal “ sphincter” and massive
reflux. Because of these defects we created
a pyloroplasty and a feeding gastrostomy.
By the tenth week he had partial recovery
of swallowing as his vocal cord function im
proved. There was progressive improvement
in his swallowing and phonation. At 12
weeks the fractured femur was well healed
and he sfarted to walk. Four months after
the accident the patient was discharged and
remains well more than two years after the
accident.
Case 6.— M.W.. a 35-year-old woman, was
admitted to the Ho^el Dieu Hospital, King
ston, on October 10, 1971 after an auto
mobile accident. Her multiple injuries in
cluded lacerations of the scalp, fractured
mandible, intra-abdominal bleeding, frac
ture of the pedicles of the C2 vertebra with
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Fig. 8. —Case 6. Marked mediastinal wide
ning.

slight forward displacement of C2 on C3.
Shortly after her admission she was taken
to the operating room for a laparotomy and
suturing of the lacerated liver.
In view of radiographic widening of the
upper mediastinum (Fig. 8) emergency
aortography was carried out through the
right brachial artery (Fig. 9). This showed

Fig. 9.—Case 6. Right brachial arteriogram
verifying the aortic tear and locating it in the
area distal to the left subclavian artery.
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the classical fe a tu re s of a tra n se c tio n of
the ao rta, d istal to the le ft subclavian
a rte ry . A t operation, using p a rtia l bypass,
th e ao rtic w all was found to be tran sected
over fiv e-six th s of its circum ference w ith
only a 1-cm. b rid g e of vessel w all le ft in tact.
The a o rta w as divided, th e edges w ere
trim m ed and an end-to-end anastom osis w as
carrie d out using a continuous s u tu rin g
technique.
A fte r closure, tracheostom y w as done in
view of th e u n d erly in g pulm onary contusion
and the facial in ju rie s w ith fra c tu re d
m andible and sw elling of th e o ro pharynx
and tongue.
The p a tie n t req u ired v en tilato r assistan ce
fo r 10 days. T h ere was p ro gressive im prove
m ent in h er general condition. One m onth
la te r a C low ard procedure w as done to
stabilize th e cervical spine. She has recov
ered completely and has resum ed h e r norm al
activities.
Case 7.— L.P., a 13-year-old boy, w as
bro u g h t to th e em ergency w ard of th e K ing
ston G eneral H ospital on Ja n u a ry 21, 1972
w ith m ultiple in ju rie s sustain ed in an a u to 
mobile accident. He had fra c tu re s of both
fem urs. A chest ro entgenogram showed a
widened m ediastinum and a small pneum o
th o rax on th e r ig h t side. A rig h t in terco stal
chest tube w as in serted . E m ergency tra n sbrach ial a o rto g rap h y confirm ed th e clinical
suspicion of a tra u m a tic ru p tu re of th e
thoracic aorta. T he te a r was beyond th e
origin of th e le ft subclavian a rte ry . The
p a tie n t was tak en d irectly to th e o p eratin g
room and th ro u g h a le ft thoracotom y th e
re p a ir was ca rrie d out u n d er p a rtia l fem orofem oral bypass. T here w as a large m edia
stinal hem atom a, and a tra n sv e rse te a r in
th e thoracic a o rta involved p ractically th e
en tire circum ference. The n arro w b rid g e of
aortic wall th a t rem ained was tran sected
and an end-to-end anastom osis w as p e r
form ed. H is recovery w as uncom plicated.
T reatm en t fo r th e m usculoskeletal in ju rie s
is b e'n g continued.

D isc u ssio n

A lthough, sines th e effective control
of syphilis, m ost thoracic aneurysm s are
a ttrib u te d to atherosclerosis, tra u m a tic
ru p tu re recently h as become a sig n ifi
cant cause. In a series reported by
Debakey et a l 3 in 1958, trau m a ac
counted fo r only 15% w hereas in 1965
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M cC lenathan an d B re ttsc h n e id e r4 re 
ported th a t 28% of all th o ra c ic an e u 
rysm s seen fro m 1953 to 1964 w ere th e
resu lt of trau m a. T ra u m a tic ru p tu re of
th e thoracic a o rta is common in h ig h 
speed autom obile accidents. In his re 
view of 72 au topsies in 1947, S trassm ann5 noted th a t 70% of th e deaths
w ere caused by m otor vehicle accidents
w hereas 86% of cases rep o rted by Mc
C lenathan and B re ttsc h n e id e r4 in 1965
w ere due to such accidents.
Pathogenesis and Mechanism of
Rupture

The m a jo r m echanical fa c to rs leading
to d isruption of th e a o rta have been
described as sudden deceleration in th e
ho rizo n tal or v ertical plane w ith devel
opm ent o f sh earin g and tra c tio n forces,
com pression of th e chest, a n d in tr a 
vascu lar b u rstin g tension. H ow ever, in 
tra v a s c u la r b u rstin g tension is probably
not sig n ifican t because, b efore r u p tu r 
ing, a norm al a o rta can w ith sta n d in te r 
nal p ressu res of up to 2000 m m . H g.6
The m a jo r disru p tiv e forces a re those
applied around th e fixed and m obile seg
m ents of th e a o rtic arch. The m ed ia
stin al fix atio n of th e ascending a o rta ,
a o rtic arch and th e descending th o ra c ic
a o rta varies. The tra n s v e rs e a rc h is
relativ ely fixed com pared w ith th e a s
cending and descending a o rta . T he m ost
vulnerable point is th e ju n ctio n of the
a rc h and th e descending th o racic a o rta
a t th e a o rtic isth m u s.2 T e a rin g a t th is
point is th re e tim es as fre q u e n t as in
th e ascending and descending po rtio n s
of th e tho racic a o rta .2,6 The ligam entum
arte rio su m no doubt plays a p a r t in fix 
ing th e isthm us a n d th u s in th e in 
creased incidence of te a rs in th is p a r 
tic u la r location. In 13 of the 14 p a tie n ts
rep o rted by M cC lenathan and B r e tt
schneider an d in all seven of o u r p a 
tie n ts the ru p tu re took place a t th is
site.
M ost a o rtic tea rs a re lin e a r and in 
volve p a rtia l o r com plete tra n se ctio n of
th e v e sse l: others a re spiral. T his su p 
p o rts th e belief th a t sh e a rin g fro m su d 
den deceleration produces these lesions.
O ccasionally stellate in tim al and m edial
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tears are found, which may be the result
o f a compressive disruptive force.
Diagnosis
The surgeon must think constantly of
aortic injury when he evaluates any
blunt chest trauma. In 194 patients with
chest injuries from car accidents Molnar
and Pace1 found that one out of four
had major injuries of intrathoracic or
gans and one in 26 had traumatic rup
ture of the thoracic aorta. Coexisting
cerebral trauma, multiple fractures and
internal injuries were frequent. More
over, a patient may have a thoracic
aortic tear with no gross evidence of ex
ternal injury. Flail chest appears to be
uncommon4 but three of our seven pa
tients had “ stove-in” chests. Parmley
et al,2 reviewed 275 autopsies of cases of
non-penetrating injuries of the aorta
and found that about 80% of these pa
tients die before reaching a hospital. Of
the rest, four of five live for one hour
to several days before a fatal hemor
rhage ensues; the fifth develops his
aneurysm several months to years later.
One of our patients had a sudden exsan
guinating hemorrhage just as the diagnois was made. Four remained stable
for several hours. Two presented with
an aneurysm three months and 10 years
after the accident.
In the period immediately after trau
ma the clinical manifestations of aortic
injury may be obscured by the severity
and extent of associated injuries.
Craniocerebral trauma was the domi
nant injury in two of our patients and
the aortic lesion was not detected until
much later. Fracture of the thoracic ver
tebrae should alert the surgeon to the
possibility of aortic injury. Any major
chest trauma, however, should arouse
his suspicion of a possible associated
injury to the aorta. The diagnostic triad
is (1) crushing chest trauma, (2)
widening of the superior mediastinum
and (3) hemothorax. Dyspnea, tachy
cardia, hemoptysis, cyanosis, paraplegia
and precordial pain have all been re
ported. Extremely helpful signs are: an
increase in the girth of the lower part of
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the neck, a diminished or absent left
radial pulse, a systolic murmur usually
heard best in the left paravertebral area
of the upper chest, and the development
of upper limb hypertension with dimin
ished or absent femoral pulses. These
last two signs are considered to be diag
nostic of aortic rupture.4 At times the
systolic murmur is audible in the supra
sternal notch.
Radiographs demonstrating a widened
mediastinum must be interpreted as
aortic rupture until this diagnosis is
otherwise disproved. One must never be
satisfied with an apparently normal ini
tial film ; serial radiographs are man
datory. Whenever there is widening of
the mediastinum, emergency aorto
graphy should be carried out. This pro
cedure usually verifies the diagnosis and
locates the site of the aortic tear thus
dictating the appropriate surgical ap
proach. In contrast to Katz and Briggs7
who introduce the catheter via the
femoral artery, we believe the aortogram should be done by the right bra
chial route to avoid any catheter mani
pulation at the site of the aortic tear.
This will avoid any delay arising from
difficulty in passing the catheter
through the damaged segment. More
over, this approach does not incur the
risk of disrupting the adventitia which
is usually all that contains the pul
sating hematoma.
In the presence of severe blunt chest
trauma, even where there are no radiol
ogic signs of aortic rupture initially,
one should do serial radiographs because
traumatic aneurysms may show up
days, months or even years after the
original injury.8
Pathology
Parmley et al.* classified non-pene
trating thoracic aortic injuries as fol
lows: (1) intimal hemorrhage, (2) intimal hemorrhage with laceration, (3)
complete laceration of the aorta, (4)
false aneurysm formation and (5) peri
aortic hemorrhage. The findings in our
seven patients may be classified as
follows: complete transection (Cases 2
and 4) ; partial laceration with false-
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In their comprehensive review of the
subject, Cole and Gutelius13 pointed out
that left subclavian artery bypass is not
free from neurologic complications and
should not be used. Dumanian et al
reported the use of deep hypothermia
and total circulatory arrest. In two suc
cessful cases this form of protection
permitted 28 and 26 minutes of total
circulatory arrest. We believe, however,
that femoral vein-to-femoral artery by
Treatment
pass, using partial pump support with
The treatment of acute rupture of the an oxygenator and filter in the system,
thoracic aorta demands restoration of is the safest and most versatile tech
the continuity of the disrupted vessel, nique to provide distal flow during the
preferably by primary repair. Where repair. The pressure above the clamp is
this is not possible a prosthetic graft recorded from the right arm. Continu
ous electroencephalographic recordings
should be interposed.
While hemorrhage, infection and are made. By maintaining the right
phrenic and recurrent laryngeal nerve brachial pressure at or near normal
palsy may complicate the repair of aor levels— 100 to 120 mm. Hg— one can
tic rupture, spinal cord damage, the usually obtain flows of 1500 to 2000 ml./
most tragic of all, occurs in about 6% .2 min. through the pump system while
In 1951 Lam and Aram” replaced the the heart itself perfuses the brain ade
thoracic aorta with a homograft and the quately. The pressure in the distal aorta
patient developed a partial paralysis of under these circumstances is usually
the lower extremities. Ellis10 described a around 80 mm. Hg. Some advantages of
patient who had homograft replacement this type of support are: (1) the femo
eight days after aortic injury and which ral vessel cannulas can be introduced
required aortic clamping for 96 minutes; under local anesthesia before the induc
the patient developed motor and sensory tion of general anesthesia; (2) the sur
loss in the lower extremities. The extent geon can initiate bypass and clamp the
of neurologic damage appears to be de aorta any time after the chest is opened;
termined by the duration of aortic oc (3) there is no tubing within the thora
clusion, the extent of aortic resection, cic cavity so that the surgeon obtains
the number of intercostal arteries lig maximal exposure of the involved area
ated and the pattern of arterial supply free from space-occupying tubes; (4)
of the spinal cord.11,12 Over the years heparinization prevents vascular throm
surgeons have sought to protect the bosis and gives added protection to the
spinal cord and other viscera from ische spinal cord; (5) there is satisfactory
mic damage by creating intraluminal perfusion to both the proximal aortic
or extraluminal shunts, by hypothermia compartment and the distal vital or
and by various forms of partial extra gans; (6) when required, the surgeon
corporeal circulation. This last is prob can easily institute total cardiopulmon
ably the method of choice and may be ary bypass; (7) if necessary, the blood
achieved in one of the following ways: that has escaped into the thoracic cavity
(1) left subclavian-to-femoral artery can be suctioned into and filtered in the
bypass, (2) left atrium-to-femoral ar pump system to restore circulatory
tery bypass or (3) femoral artery-to- blood volume rapidly.
Operative mortality during, and mor
femoral vein bypass. Whichever of these
three methods he uses, the surgeon bidity after, surgical repair of acute rup
needs a thorough understanding of the ture depend largely upon the severity of
normal anatomy and possible variation associated injuries and their prompt
diagnosis and treatment. With this type
in the blood supply to the spinal cord.13
aneurysm formation and calcification of
the wall (Case 1) ; transection of onehalf the aortic circumference with intact
adventitia and periaortic hematoma
(Case 5) ; four-fifths transection, dis
section, hematoma and aneurysm forma
tion (Case 3) ; and transection with an
intact 1-cm. bridge connecting the tran
sected edges, with false aneurysm for
mation (Cases 6 and 7).
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of approach in the emergency situation,
treatment is successful in most patients.
With modern techniques of partial
extracorporeal circulation and improved
prosthetic grafts, elective resection of
the descending thoracic aortic aneurysm
has become common. Cooley resected
aneurysms of the aortic isthmus in 60
patients several months to years after
trauma without any deaths.15 The un
resolved question in operations for any
'small chronic post-traumatic aneurysm
that is asymptomatic and shows no
signs of enlargement relates to the un
predictability of spinal cord damage.
The extent of resection, the number of
intercostal arteries that must be inter
rupted and the varying patterns of
spinal cord blood supply are crucial fac
tors in this unpredictability. For this
reason some authorities recommend that
patients with chronic aneurysm be close
ly followed and the aneurysm be re
sected only if there is clinical change,
symptoms, or radiologic enlargement.
While Cooley and DeBakey’6 estimated
that patients with thoracic aneurysm
had only six to eight months to live,
their series was composed chiefly of
syphilitic and atherosclerotic aneu
rysms. Others give a much more favour
able prognosis in asymptomatic trauma
tic aneurysms. Of Steinberg’s patients17
three were living at 21 to 27 years and
one patient two years after trauma. One
patient who had been asymptomatic for
five years died after resection. Joyce
et al.1* described patients thought to
have traumatic aneurysm who survived
at least nine years and commented on
the favourable outlook. One of our pa
tients is alive and well five years after
his traumatic aneurysm was discovered
and 15 years after the original injury.
Cough, dyspnea and pain in the back
due to pressure on the vertebral column
should warn the surgeon that the aneu
rysm is expanding and provide an in
dication for elective resection. Even
though the aneurysm produces no symp
toms, if periodic radiographs show an
increase in size, surgical repair should
be recommended. In the absence of these
features and until we can delineate the
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great radicular artery accurately and
safely, some traumatic aneurysms must
be managed conservatively by periodic
radiographic follow-up.
Sum m ary

In the period 1967 to 1972 seven pa
tients sustained traumatic rupture of
the thoracic aorta at the aortic isthmus
following automobile accidents and pre
sented at the Kingston General and
Hotel Dieu Hospitals. One died before
confirmation of the diagnosis. Four had
emergency surgical repair. One had re
section and insertion of a graft four
months after the accident. Another pa
tient who presented with a chronic,
heavily calcified aneurysm is being man
aged conservatively and is well 15 years
after the initial trauma. There was no
surgical mortality.
Since only one out of every 20 pa
tients who sustain traumatic rupture of
the thoracic aorta survives for longer
than three weeks, surgical correction
with primary repair or prosthetic graft
ing must be carried out when the diag
nosis is made early. The surgeon must
think of aortic injury in every patient
with multiple trauma and blunt injury
to the chest. A diminished or absent left
radial pulse and a systolic murmur in
the left paravertebral area of the chest
are extremely helpful signs in making
the diagnosis. Widening of the media
stinum in the chest radiograph makes
aortography mandatory. The aortogram
verifies the diagnosis and locates the
site of the tear. In selected asymptoma
tic small aneurysms detected months or
years after injury, conservative man
agement by regular follow-up is consi
dered justifiable.
A ddendum

Since the submission of this paper for
publication a 37-year-old man was found to
have a “mediastinal mass” on a routine chest
radiograph. Investigation revealed this to be
a typical traumatic thoracic aortic aneu
rysm distal to the left subclavian artery.
It was believed to have been sustained in a
motor vehicle accident in 1964, at which
time the patient suffered head injury with

unconsciousness, chest injury, prolonged
sternal pain and fractured ribs, and a fra c
tured femur. A t the time o f its discovery
the aneurysm was entirely asymptomatic.
It was elected to examine the patient at
intervals according to the principles out
lined in this report.
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R esum e

Au cours de la periode de cinq ans de 1967
a 1972, sept malades ayant subi une runture
traumatique de l’aorte thoracique au niveau
de l’isthme aortique. au cours d’accidents de
la route, ont ete admis dans deux hopitaux
de Kingston, Ontario (le Kingston General et
l’Hotel-Dieu). Un de ces accidentes est mort
avant aue le diagnostic ait ete confirme. Quatre patients furent operes d’urgence. Un autre
subit une resection et une greffe quatre niois
apres Taccident. Un autre malade, oui presentait en outre un anevrysme chronique fortement calcifie, est traite par des moyens conservateurs et se porte bmn 15 ans apres le
traumatisme original. On n’a enregistre aucune
mortality operatoire.
Etant donne que, parmi les malades qui sont
victimes d’une rupture traumatique de l’aorte,
un seul sur 20 survit plus de trois samaines,
l’operation, refection primaire ou greffe d’une
prothese, s’impose quand le diagnostic a ete
pose precocement. Le chirurgien devra songer
a une lesion aortique chez tout patient ayant
subi de multiples trauma tismes et une blessure
contondante du thorax. Un nouls radial gauche
faible ou absent ou un souffle systolique dans
la region paravertebrale gauche du thorax sont
des signes qui facilitent grandement le diag
nostic. Un elargissement du mediastin sur la
radiographie thoracique rend imperieuse une
aortographie. Cet examen permet de verifier
le diagnostic et de localise!' le siege de la dechirure. Dans un certain nombre de cas choisis
de petits anevrysmes asymptomatiques qui ne
sont deceles que des mois ou des annees apres
Taccident. on considere comme justifie un traitement conservateur avec examans de controle
frequents.
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ELECTROLYTES OF GASTRIC JUICE COLLECTED FROM TOTALLY
ISOLATED CANINE EX VIVO STOMACHS*
K. K O W A L E W S K I, Ph.D., M.D. and R. SCHARF, M .D .,f Edm onton, Alta.
M o s t physiologists agree that the con
centration of H + in the primary sec
retion of parietal cells is higher than
that of the gastric content collected by
usual methods.1,2 The mechanism un
derlying this phenomenon is not yet
known. Numerous hypotheses have been
proposed to explain not only the me
chanism of H+ production but also the
variations in the ionic composition of
gastric juice associated with the
changes in gastric acidity. The subject
of electrolytes of mammalian gastric
juice was reviewed recently by Hunt
and Wan,2 who discussed various hypo
theses in detail and examined them
critically. The majority of these hypo
theses agree that the variations of H +
concentration and osmolarity of the gas
tric juice depend mainly on secondary
factors, e.g. buffering by non-parietal
gastric secretion, back diffusion of ions
operating after the elaboration by the
parietal cells of a theoretical “ primary”
acid gastric juice of variously described
composition.2,3
The most important difference be
tween these hypotheses is the inter
pretation of the relationship between
Na+, H + and Cl and quantitative char
acterization of this relationship. Vari
ous conditions under which the gastric
juice is collected by the students of gas
tric electrolytes may be, in part, respon
sible for some differences in ionic meas
urements. Human gastric secretion may
be contaminated (saliva, duodenal
ju ic e ); experimental canine pouches
may not represent total mucosa (Heidenhain pouches and fundic isolated
segments) and are deprived of the an
trum, which is an important producer
of alkaline component.4
*From the Surgical-Medical Research Institute
and Department of Surgery, The University
of Alberta, Edmonton, Alta.
(■Fellow in Experimental Surgery, supported
by the Edmonton Civic Employees Association.
Present address: Institute of Hematology,
Warsaw, Poland.

For the last seven years we have been
using a preparation that permits the
collection of pure gastric juice from
a total ex vivo canine stomach. Such
an isolated organ can be perfused with
homologous or autologous blood for at
least 24 hours, and stimulated gastric
secretion can be obtained during this
perfusion period.511
We previously reported mainly on H !
and pepsin secretion of ex vivo canine
stomachs. The purpose of the present
study was to investigate the ionic com
position of pure gastric secretion col
lected from ex vivo canine stomachs and
to analyze quantitatively the relation
ship between the major electrolytes in
this secretion.
M ethod

Perfusion System
The perfusion chamber and the cir
cuitry of perfusion were previously de
scribed in detail.9' 12 Only the most
pertinent information will, therefore, be
repeated (Fig. 1). The perfusion cham
ber housing an ex vivo organ assures
a precise control of temperature, humid
ity and pressure. Blood is delivered to
the stomach with the help of an oc
clusive roller pump (Sarns low-flow per
fusion pump, No. 5M-6050, Travenol
Laboratories Ltd., Alliston, Ont.). A r
terial blood-flow rate can be arbitrarily
varied by adjusting the pump speed
selector, or it can be controlled automa
tically to deliver a constant, selected, ar
terial perfusion pressure. The latter
facility utilizes a feedback channel re
sponding to the galvanometer voltage
from an arterial pressure channel on a
recorder (Offner Type R biomedical
recorder, Beckman Instruments, Inc.,
Palo Alto, Calif.). The height-adjust
able reservoir receives venous outflow
blood from the stomach. A second roller
pump (Sarns modular pump No. 5M6002) returns blood to the supporting
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STIMULANT INFUSION PUMP

Fig. 1.—Circuitry for e x vivo perfusion of isolated canine stomach. A supporting dog or
a bubble oxygenator is supplying perfusion blood with oxygen.

animal or an oxygenator, at a rate that
is automatically controlled by photoelec
tric sensing of the blood level in a
venous reservoir.12 A small amount of
blood escaping from the preparation is
delivered, by a third pump, to the
venous circuit. Priming volume of the
entire flow circuit is 200 ml. Oxygena
tion of perfusion blood takes place in
a supporting dog or in an oxygenator
(Fig. 1). The supporting dog, previous
ly gastrectomized and under sodium
pentobarbital anesthesia, breathes spon
taneously during the perfusion. How
ever, intermittent positive-pressure hy
perventilation is carried out and oxy
gen insufflation is provided if arterial
pOa is less than 60 mm. Hg. For extra
corporeal perfusion we use a bubble
oxygenator (Mini-prime 2LF, total body
perfusion oxygenator, Travenol Labora
tories, Inc., Morton Grove, 111.), which
is indicated in Fig. 1. This oxygenator
receives pure oxygen or an appropriate
mixture of oxygen and carbon dioxide
delivered under manometric control.

Isolation of the Stomach

The stomach of a dog, fasted for 18
hours, is dissected carefully, avoiding
any handling of the organ and working
essentially on the vascular system. Ma
jor steps of dissection are: (a) splenec
tomy and subtotal omentectomy, (b)
ligation and division of the infraceliac
aorta, (c) division o f the thoracic aorta,
(d) division of the retroperitoneal at
tachments of the paraceliac aorta, and
(e) division of the distal portal vein.
The dissected organ is weighed and im
mediately placed in the chamber so as to
rest on the ventral wall. The transfer
period, equivalent to the complete arrest
of circulation, lasts from four to nine
minutes.
Perfusion

Stomach vasculature is connected
with the perfusion circuit by the prece
liac segment of the aorta and the distal
portal vein, using appropriate cannulas.
The outlet of the intragastric cannula,
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secured by a ligature around the duo
denal sphincter, is placed outside the
chamber. The chamber is sealed and in
termittent respiratory-rate pressures of
+ 8 /+ 3 mm. Hg are produced using res
piratory pumps (Fig. 1). Venous reser
voir height and pump volumes are ad
justed to produce a pressure of + 8 /+ 9
mm. Hg in the portal vein. During the
first 15 to 20 minutes of perfusion the
stomach, which was not washed after
dissection, is permitted to drain spon
taneously. Most of the preformed se
cretion is evacuated by this method.
When circulation in the system is well
stabilized and the stomach is emptied,
we begin intra-arterial infusion of his
tamine dihydrochloride, 150 /xg./hr. The
body weights of donors of ex vivo
stomachs varied from 20 to 24 kg. Ini
tial weights of isolated stomachs ranged
from 295 to 386 g.
Measurements
Arterial and portal venous pressure
and arterial flow rate were constantly
monitored during the perfusion (Zepeda
EPD-2RD, Zepeda Instruments, Seattle,
Wash.). Arterial and venous pCL, pCCL
and pH were measured every 30 min
utes. Stomach oxygen consumption was
calculated, using arterial flow rate and
arteriovenous oxygen content differ
ences. Gastric juice was collected con
tinuously in 30-minute samples. Gastric
acidity was determined with an automa
tic titrator (Radiometer Model TTT1
titrator). This method permits the re
cording of the total titratable (to pH
7.0) H +, representing HC1 that is com
pletely dissociated, and that buffered
by the presence of other substances. The
concentrations of Na+ and K + were de
termined using a flame photometer
(I.L. Model 143). Chloride was meas
ured with a chloridometer (BuchlerCotlove model) and calcium was deter
mined photometrically.13
The results of biochemical studies of
gastric juice ions were processed with
the help of a computer. The regression
analyses of paired data for H +, Na+
and Cl“ were carried out using the tech
niques described by Smillie.14 The pro-

TABLE I. — Secretion

of
E x V ivo C anine
by
C onstant I ntra
arterial I nfusion of H istamine (150 iaG ./ hr .).
D uration of P erfusion A veraged S ix H ours
(4.0-8.0). Samples T aken E very 30 M inutes.
M ean and R anges ( in B rackets )

Stomachs

Stimulated

Perfused with blood circul
ating through
Components
No. of stomachs
No. of 30-min. samples
Gastric juice
Vol. ml./30 min.
HC1 mEq./30 min.
H+ mEq./l
Na+ mEq./l.
K+ mEq./l.
CL mEq./l.
Perfusion blood
Na+ mEq./l.
K+ mEq./l.
CL mEq./l.
Hematocrit (%)
Arterial pH
Arterial blood
flow /ml. /min. /stomach
0 2 consumption
ml./min./stomach

Supporting
dog
25
268

Bubble
oxygenator
8
115

37
(12-98)
4.8
(1.2-7.5)
97
(4-1.67)
56
(6-139)
6.6
(2.3-12.3)
154
(110-181)

37
(7-72)
0

146
(128-165)
6.1
(4.0-11.0)
120
(116-146)

147
(140-149)
3.5
(3.2-3.8)
110
(107-126)
40
(38-43)
7.30
(7.15-7.49)
110
(60-150)
2.21
(0.70-6.00)

150
(141-174)
3.4
(3.0-4.1)
116
(100-135)
34
(28-52)
7.30
(7.15-7.54)
108
(70-170)
1.20
(0.50-1.98)

0

gram SR was run on the University of
Alberta IBM 360/67 computer. For cal
culations of significance Student’s t test
was used.
R esults

Table I summarizes the results ob
tained in two series of ex vivo stomachs.
It can be noted that all stomachs sup
ported by a living dog-oxygenator pro
duced secretions containing H +. All
stomachs oxygenated in vitro (bubble
oxygenator) produced alkaline juice. No
marked differences were noted between
the composition of blood in the two sys
tems. Oxygen consumption was, how
ever, higher in H +-producing stomachs
than in stomachs which secreted only
alkaline juice.
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[H+] mEq./L
Fig. 2.—Relationship between the concentra
tions of H + and C l- . Regression line is given
by the equation: [C l- ] = 137.8 + 0.1775 x
[H +] mEq./l. The standard error o f the slope
is 0.1266. The correlation coefficient = 0.652,
t is 14.0 and N = 268.

Fig. 3.—Relationship between the concentra
tions o f H + and Na +. Regression line is given
by the equation: [N a +] = 127.5 — 0.7363 x
[H +] m E q./l. The correlation coefficien t =
-0.962, t is 57.8 and N = 268.

Fig. 2 contains the paired concentra
tions of H + and Cl“ . The line represents
the least-squares best fit for a straight
line. The equation of the line is [Cl~] =
137.8 + 0.1775 x [H +] mEq./l. The
standard error of the slope was 0.1266,
the correlation coefficient was 0.652, t
was 14.0 and N = 268. The straight line
gives a reasonable fit to the data, and
any curved line would evidently not
yield a smaller sum of squares of devia
tions. While the standard error of the
slope is considerable, there is clearly a

relationship and the value of t is very
large. The probability that the observed
slope is not significant is thus exceed
ingly small (P < .001).
Fig. 3 shows the relationship between
the concentrations of Na+ and H +. The
equation o f the linear regression line is
[N a+] = 127.5 - 0.7363 x [H +] m Eq./l.
The correlation coefficient was -0.962,
t was 14.0 and N = 268. The question
whether a curved line of any sort would
give a closer fit to the data was con
sidered. Unless the data were selected,

TABLE I I —C omparison of the C alculated Primary C oncentrations of the N on-parietal C ompo
nent (M akhlouf, M cM anus and C ard) and the D ata O btained F ollowing G astric Intra -arterial
Infusion (Altamirano) or T opical A pplication of A cetylcholine (Hollander) W ith our R esults
in Ex Vivo C anine Stomachs, Perfused W ith B lood C irculating T hrough a B ubble O xygenator .
M ean V alues

Component
Na+....................
K+......................
Cl- .....................

Makhlouf,
McManus and Card16
in man

Altamirano 34
in dog*

136.7
6.4
117.0

137.8
3.5
116.0

‘ Isolated segments of canine gastric fundi, in vivo.
tHeidenhain pouch,
t Compare with Table I.

Hollander 17
in dogt
133.0
4.4
120.0

Our results in ex
vivo canine stomacht
146 0
6.1
120.0
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T A B L E I I I — C omparison of E lectrolyte C oncentration in G astric M ucinous Secretion (H ol 
lander ) and the C oncentration of E lectrolytes in the Secretion of E x V ivo C anine Stomachs
W ith E lectrolytes of D og P lasma. N umber of 30-M inute S amples was 115. M eans and R anges ( in
B rackets )
Hollander17 *
Component
N a+
K+
Ca++
CD
HCOs

Mucinous secretions
133.0
4.4
3.7
120.0
13.0

(114 - 148)
(2.5 - 6.9)
(2.4 - 5.0)
(96 - 144)
(6.5 - 29.8)

*

Ex vivo stomachsl
Dog plasma
(135 - 169)
(3.7 - 6.2)
(4.5 - 6.1)
(99 - 136)
(18 - 24)

Gastric juice
146.0 (128 - 165)
6.1 ( 4.0 - 11.0)
4.0 ( 2.7 - 6.0)
120.0 (116 - 146)
14.0 ( 8.0 • 24.0)

Perfusion blood (plasma)
150.0
3.4
5.0
116.0
17.5

(141 - 174)
(3.0-4.1)
( 5.6 - 6.4)
(100 - 135)
( 14 - 26)

•Heidenhain pouches stimulated by acetylcholine.
tTotal canine ex vivo stomach, stimulated by histamine and perfused with autologous or homologous
blood circulating through a bubble oxygenator.

a curved line would not, in our opinion,
significantly lower the sum of the
squares of the deviations.
In Tables II and III we compared the
results obtained by the analysis of alka
line gastric juice in our study with the
results reported by other authors who
investigated non-parietal or alkaline
component of gastric secretion. It may
be noted from these tables that the over
all composition of alkaline secretion ap
proaches the ionic composition of blood
serum or extracellular fluid.
D

is c u s s io n

The ex vivo preparation described
above differs considerably from the
preparations used by previous students
of gastric electrolytes. The ex vivo
stomach produces pure juice, which is
not contaminated by saliva or duodenal
content. The ex vivo stomach also in
cludes the antrum, a rich source of nonparietal secretion, and in this regard
differs from fundic pouches used for
the study of gastric juice electrolytes in
experimental animals.
Major Ions of Gastric Juice
Every ex vivo stomach, perfused with
homologous blood of a living supporting
dog and stimulated with histamine, pro
duced a secretion containing H +. The
range of acidities obtained in 268 30minutes samples varied from 4 to 167
mEq./l. The highest concentration of
H + found in this series was therefore
quite similar to the value of 160 mEq./l.

reported as the maximal concentration
of H + for in vivo stomachs.2 The con
centration of CD, the major anion of
gastric juice, varied from 110 to 181
mEq./l., the maximal value obtained
being 181 mEq./l. This again compares
well with the maximal value of 179
mEq./l. found in histamine-stimulated
human gastric juice.15 Also, the ranges
of K + reported for human gastric
juice16 and dogs with fundic pouches17
are similar to the range found in our
study.
Finally, the values for Na+ in this
study varied from 6 to 139 mEq./l. They
consistently declined when H + secretion
was stimulated and they increased at
low acidities. In human subjects the
concentration of Na+ also reached its
highest values at the same time as acid
ity approached neutrality.16
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Relationship Betiveen Concentration
of H + and Cl~
It was reported previously that the
relation between concentration of CD
and ED may be expressed as rectilinear.
Such a regression line was obtained by
Hollander18 and Gray and Bucher19 who
analyzed pooled samples of canine juice.
According to Hunt and Wan2 the weak
ness of the rectilinearity concept2 is the
small range of acidities studied. These
were, respectively, 100 to 160 mEq./l.18
and 90 to 140 mEq./l.19 in the reports
quoted. Despite this narrow range of
acidities, a rectilinear regression line
was established by extrapolation to 170
mEq./l. of CD and to zero concentration
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o f acid.2,18 This method of extrapolation
may be open to criticism.2
The concentration of acid varies, usu
ally between 0 and 150 mEq./l.2The con
centration of chloride increases linearly
with the concentration of acid but only
over a limited range.2, 18, 20-22 Some diffi
culties occur when the results are
examined over the range 0 to 170 mEq./
1.; in these areas, according to Hunt
and Wan,2 the relation is expressed best
as curvilinear.
In our study the range of acidities is
extremely large (4 to 167 mEq./l.) and,
in this respect, we would be safe from
Hunt and Wan’s criticism.2 Preparing
the regression line for H + and CP, we
did not need to extrapolate to zero or to
maximal concentrations. A straight re
gression line fitted the data well, par
ticularly the central part of the graph.
It is possible also to express the extrem
ities of this line as parabolic. Riddell,
Strong and Cameron,23 discussing the
numerical estimate of Na+ and H + rela
tionship, found that the extremities of
the regression line were best expressed
as parabolic. They concluded, however,
that this was unnecessary refinement
which might lead to fallacious conclu
sions. They accepted the straight line
as most realistic. They noted that, at the
extremities of the line, some observa
tions were “ erratic” . “ The inequality of
errors in observation of the small vari
able could make the regression line
curved at its ends.” 23 We accept the
comment of these authors23 as a guide
line in evaluation of our regression
lines, and feel that in the absence of
compelling evidence the simplest inter
pretation is the most satisfactory.
Relationship Between Concentration
of H + and Na+
Hollander18, 24, 25 and
Gray
and
Bucher19 concluded that there was a rec
tilinear relationship between concentra
tion of H + and Na+. Riddell, Strong and
Cameron,23 after the above-mentioned
comment, also preferred the straight re
gression lines to other estimates of the
association between the concentrations
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of these two ions. Milton, Skyring and
George26 found, in cats, the concentra
tion of Na+ and H + ranging from 0 to
120 m Eq./l.: the plot of concentrations
of these two ions was rectilinear. Some
authors obtained a rectilinear relation,
in human gastric juice, between H + and
Na+ but only at the limited range of
acidities.20, ” •27-29
Hirschowitz15 made repeated studies
in one human subject and found that
linear correlation between H + and Na +
was “ good” , but there was also “ a cur
vilinear trend” . Such a trend and its
significance were discussed by Riddell,
Strong and Cameron23 quoted above. It
should be mentioned that some of the
important studies predicting a cur
vilinear relation between concentration
of H + and Na+ are based on the evalua
tion of reabsorption of HC1 instilled
into the stomachs of animals.30-32 Such a
method cannot be compared with our
collection of pure gastric juice in totally
isolated stomachs. Two important stu
dies of histamine-stimulated human gas
tric secretion, one by Makhlouf, Mc
Manus and Card16 and another by Nordgren,33 support the concept of a rec
tilinear relation between the concentra
tions of H + and Na+ in gastric juice. It
appears therefore that our results re
garding the relationship between con
centrations of H + and Na+ in the pure
canine gastric juice, collected from ex
vivo stomachs, agree with findings in
in vivo human and animal gastric secre
tion.
Sum of the Cations and Anions of
Gastric Juice
An important relationship between
Cl” and the sum of H +, N a+ and K + of
gastric juice deserves a short discus
sion. This relationship can be expressed
by an equation stating that total Cl"
approaches the sum of Na+ + K + + H +
over a certain range of Cl“ values. This
indicates that Cl“ , for all practical pur
poses, is the only anion in gastric juice.15
This equation is evidently a simplified
one.17 We compared the sums o f H +, K +
and Na+ with Cl" using 176 samples of

366

THE CANADIAN JOURNAL OF SURGERY

30-minute secretions. We obtained for
the sum of the cations the value 164.4
± 14.5 mEq./l., and for Cl" the value
160.4 ± 13.0 mEq./l. The ranges for
H +, K +, Na+ were respectively: 7 to
167; 2.9 to 12.1; and 4 to 139; and for
Cl" the range was 126 to 181. Close
similarity between the sum of cations
and the value for Cl" seems to indicate
that the above-mentioned equation was
verified in the present experiment.
Alkaline Gastric Juice
In none of the ex vivo stomachs per
fused with autologous or homologous
blood circulating through a bubble oxy
genator was gastric juice H + detected
by the method used. The cause of this
“ functional block” of parietal cells is
not known. That this is not a permanent
block, due to damage, but a transitory
arrest of function was proved in the
following experiment, which will be
reported separately: when a supporting
dog is connected to the perfusion system
(Fig. 1) and the bubble oxygenator re
moved, ex vivo stomachs, previously
resting as far as H* secretion is con
cerned, start to produce acid. In the
presence of the bubble oxygenator, only
alkaline juice is produced.
Alkaline gastric juice was sometimes
recovered from patients with various
gastrointestinal disorders. Besides this
indirect evidence for non-parietal sec
retion,2 some experiments show directly
the production of non-parietal, alkaline
juice.2’ 15,” ■2I>“ •34. When acetylcholine
was given intra-arterially,34 alkaline
juice was produced by the fundic
pouches of dogs. Similar results were
obtained by others.” Altamirano34 found
that concentrations of ions of the
“ pure” postacetylcholine alkaline secre
tion were characteristic of an ultrafil
trate of plasma to which has been added
the secretion of the mucous cells. The
final fluid was iso-osmotic with plasma.
Hollander”
introduced acetylcholine
topically into Heidenhain pouches and
obtained the juice free of cells and of
H +. He states that the mucinous secre
tions so obtained had an electrolyte pat
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tern essentially the same as that for dog
plasma or interstitial fluid.
We compared the previous data on
non-parietal secretions16, ” •34 with those
in our experiment (Tables II and III).
It may be observed that alkaline secre
tions from the ex vivo stomach have a
composition approaching that of blood
plasma. Higher gastric juice sodium in
our series may be due to the presence of
the antrum, absent in the preparations
of Altamirano and Hollander. Of partic
ular interest is the similarity between
Cl" in all four series (Table II). Alka
line juice obtained in our experiment
appears comparable, in regard to the
composition of electrolytes, to nonparietal juice found in human subjects
and dogs studied in in vivo conditions.
In summary, then, a linear relation
ship was shown to exist between the
concentrations of Na+ and H + and be
tween the concentration of Cl" and HC
We were able to analyze a large popula
tion of 30-minute samples (268) of gas
tric juice. The range of acidity in this
series was very large and no extra
polation to extreme values of concentra
tion of H + or Cl" was necessary. In this
way a criticism of “ too-narrow range”
forwarded by Hunt and Wan,2 and dis
cussed above, could be easily avoided.
Regarding the composition of “ nonparietal component” , which was found
in alkaline juice of oxygenator-sup
ported stomach, this component was
shown to be nearly identical with plas
ma (and interstitial fluid).
Our present experiments show that in
a pure gastric secretion, obtained from
a totally isolated canine stomach, ionic
composition is generally similar to that
observed in in vivo conditions in man
and animals.
Summary

The perfusion-oxygenation of totally
isolated canine ex vivo stomachs was
studied using two systems: System I
contained a living “ supporting dog”
which served as oxygenator-dialyzer of
circulating homologous blood. System II
contained a bubble oxygenator. All
stomachs perfused with System I and
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9.
stimulated intra-arterially with hista
mine secreted gastric juice containing
H ‘ . However, the histamine-stimulated
stomachs perfused under System II pro
duced only alkaline juice. Regression 10.
lines were prepared by computer for the
concentration, in gastric juice, of H+
versus Cl~ and for the concentration of 11.
H+ versus Na+. In both instances the
relationship was found to be rectilinear.
Analysis of alkaline juice obtained from
12.
stomach perfused with “ System II” de
monstrated that the ionic composition
of this non-parietal secretion ap 13.
proached the ionic composition of blood
serum of perfusion blood. Our results
were compared to those of various 14.
authors who studied ionic composition
and exchange in the stomachs of human 15.
subjects and experimental animals.
We are grateful to the following persons
for their assistance: Mr. A. Kolodej and Mr.
R. Orchard for their valuable assistance with
the surgery and perfusion experiments; to
Mrs. M. McCubbin and Mr. T. Pachkowski who
performed biochemical tests and made statis
tical evaluations of the results, and to Dr.
J. C. Russell who prepared the analysis of
regression lines from the computer data.
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R esum e
Les auteurs ont etudie la perfusion et l’oxygenation d’estomacs canins ex vivo totalement
isoles. Ils ont, a cet effet, utilise deux systemes: le systeme I comportait un “ chien de soutien” vivant qui servait d’oxygenateur et de
dialyseur de sang homologue circulant. Le
systeme II comportait un oxygenateur a bulles. Tous les estomacs perfuses par le systeme
I et stimules par injection intra-arterielle
d’histamine ont secrete un sue gastrique contenant H +, tandis que les estomacs stimules
par l’histamine et perfuses dans le systeme II
n’ont secrete qu’un sue alcalin. Les auteurs ont
prepare par ordinateur les courbes donnant la
concentration dans le sue gastrique, de H +
par rapport a CL~ et la concentration entre
H+ et Na+. Dans les deux cas, le rapport obtenu etait une ligne droite. L’analyse du sue
alcalin secrete dans les estomacs perfuses par
le systeme II a mis en lumiere que la compo
sition ionique de cette secretion non parietale
etait voisine de celle du serum sanguin du
sang transfuse. Nous avons compare nos resultats a ceux d’autres auteurs qui avaient etudie
la composition et les echanges ioniques dans
des estomacs humains et des animaux d’experience.
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CANCER OF THE COLON IN PATIENTS WITH ULCERATIVE
COLITIS SINCE CHILDHOOD*
GHISLAIN J. DEVRO ED E, M .D.,f MALCOM B. DO CK ERTY, M.D.,
W ILLIAM G. SAU ER, M.D., RAYM ON D J. JA CK M AN , M.D. and
G U N N AR B. STICK LER, M.D., Rochester, Minn., U.S.A.

association of cancer of the large
intestine and ulcerative colitis is well
known.1'17 In a previous study we showed
that cancer of the large intestine fre
quently develops in patients who have
had ulcerative colitis since childhood.18
We now present data on the prognosis
of such cancer and describe the charac
teristics of this type of lesion.
T he

M a t e r ia l s a n d M e t h o d s

The series comprised 77 patients with
childhood ulcerative colitis (before the
age of 14 years) who later developed
carcinoma of the large intestine; in
clusion in the series was dependent on
the availability of at least one histologic
section for review. The patients were
drawn from two different groups: (1)
Follow-up of 396 children with ulcera
tive colitis18 who were seen at the Mayo
Clinic, Rochester, between December 1,
1919 and December 1, 1965, provided
data on 52 patients who developed car
cinoma of the large intestine before
December 1, 1966; histologic material
was obtained on only 40 of these pa
tients. (2) From December 1, 1919 to
December 1, 1966, 37 adults were seen
who had cancer as a complication of
persistent ulcerative colitis. As ascer
tained from the history18 and other
evidence, the colitis had begun before
the age of 14 years. All o f these 37 pa
tients had rectal disease, none had skip
areas in the large intestine and none
had regional enteritis.
From the records of the first group
of 40 patients followed at the Mayo
Clinic from childhood, we determined
the severity of their disease between the
time of diagnosis of ulcerative colitis
and the time of the subsequent diag‘ From the Mayo Clinic and Mayo Foundation,
Rochester, Minn., U.S.A.
fCentre Hospitalier Universitaire, Sherbrooke,
Que.

TABLE I.— C riteria for C lassification of
C ourse of C olitis from Follow-up of 40 P a 
tients W ith Ulcerative C olitis in W hom
Cancer D eveloped
Course
Mild

Activity
Regular

Complication
None

Moderate Confinement <1
mo. at home

Anemia, weight loss
or growth failure,
arthritic or ocular
manifestations,
erythema nodosum

Severe

Anemia ( > 10
transfusions/yr.),
recurrent phlebitis,
pyoderma gangre-

Confinement >1
mo. at home or <1
mo. in hospital

nosis of carcinoma (Table I). The path
ological specimens were studied by one
of us (M.B.D.) who at the time was not
aware of the clinical data. The chisquare test was used in the statistical
analyses. Survival curves were calcul
ated by a standard actuarial method.
R esults

Clinical Data
The ulcerative colitis was mild in 22
of the 40 patients followed from child
hood to the development of cancer.
Eleven of the 77 patients had had com
plete remissions o f one to 19 years be
fore carcinoma o f the large intestine
developed in the presence of the quies
cent ulcerative colitis.
TABLE II.— A ge D istribution at the T ime of
D iagnosis of Cancer
Age (years)

No. of patients

10-19..........................................
20-29..........................................
30-39..........................................
40-49..........................................
50-59..........................................

7
40
27
2
1

Total..........................................

77
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T A B LE III.— N ew M anifestations W hen C an
cer D eveloped in 63 P atients

TAB LE

New manifestation

Histologic type

No. of patients

Subjective:
Pain..........................................
Fatigue
Present............................................
Absent.................................
No da ta.........................................
Appetite
L oss......................................
Normal................................
No data..........................................
Constipation...........................

28
21
29
13
20
28
15

26
13
24
16
23
24

D iagnosis

of

C ancer

No.

Cancers

Adenocarcinoma.....................................
Small cell carcinom a.............................
Mucus-producing carcinom a...............
Scirrhous carcinoma............................
Adenoacanthoma....................................
Basaloid carcinoma................................
Giant cell carcinom a.............................
Carcinoid..................................................

44
4
24
20
3
1
1
2

T ota l.........................................................

99

Twenty-one of 67 patients (31% ) on
whom adequate data were available had
multiple invasive cancers. Besides an
invasive growth, 12 other patients had
multiple sites of cancer in situ. A total
of 99 invasive cancers developed in the
entire group.
The histologic features of the cancers
varied considerably (Table V, Figs. 1
and 2). The lesions were classified by
grade and site of occurrence (Table
V I). About 55% of all cancers were
either grade 3 or grade 4 (Broders’ ).
Test of homogeneity revealed that can
cers were scattered uniformly through
out the large intestine; the different
grades of tumours showed no predilec
tion for site (P > 0.05). Of 80 cancers
for which information was available,
50 (63% ) were associated with nodal
metastases. In 43 of 64 patients (67% )
on whom data could be gathered, distant
metastases had already developed when
the diagnosis was made.
Survival

Patients
Method of diagnosis

of

Pathological Findings

12
9

The youngest patient was 10 years
old and the oldest was 52 years old;
96% were less than 40 years old when
cancer developed (Table II).
Eleven patients had no new com
plaints when the cancer developed. In
63 others on whom data were available,
the most common warning manifesta
tions were pain and loss of weight
(Table III). Cancer was suspected be
fore operation in only 35 of the 75
patients (47% ) for whom data were
available. The diagnosis was made at
autopsy in four (Table IV ).
of

V.— H istologic
C lassification
C ancers

5

Objective:
Palpable abdominal mass. . .
Obstruction.............................
Weight
L oss......................................
Unchanged.....................................
No d a ta ...............................
Anemia (Hb. g./lOO ml.)
Under 10........................................
Over 10...........................................
No d a ta ..........................................

TAB LE IV.— M ethod

Vol. 15

%

Proctoscopic examination. . .
Roentgenologic examination
Surgical exploration...............
Autopsy...................................
Biopsy*....................................

15
20
35
4
1

20
27
47
5
1

T ota l...................... •................

75t

100

*Cancer o f colon not suspected on biopsy of neck
nodule.
tData not available on two patients.

The survival rates at six months, one
year and five years were 55%, 49%
and 24% respectively (Fig. 3).
D is c u s s io n

The course of cancer of the large in
testine was fulminant when it com
plicated ulcerative colitis that began
during childhood. This was confirmed
by the early age at which cancer devel
oped in the present group of patients,
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Fig. lb

Fig. 1.—(a) Grade 2 scirrhous adenocarcinoma complicating chronic ulcerative colitis. The
desmoplastic reaction induced by carcinomas often produces a lesion that is mistaken for a
stricture (H & E X 200). (b) Grade 4 adenocarcinoma. The incidence of such high-grade
(Broders’ ) lesions shows a sixfold increase over that observed among “ controls” (H & E X 60).

the multiplicity of the lesions, the high- tion. Indeed, the group of patients in
grade malignancy of most of the lesions, this study cannot be compared to a con
the frequency of regional lymph-node trol group, free from cancer, because the
involvement and distant metastasis, and classification of the course of disease
the low survival rate after the diagnosis was based on the history between the
was made. Also only one-half of the diagnosis of ulcerative colitis and the
cancers were diagnosed clinically, and onset of cancer. Thus no end point for
two-thirds already were inoperable at classification could be found for a con
that time. Survival of our group is trol group, free from cancer. However,
poorer (P < 0.01) than that of a large the present study suggests that a false
group of 15,388 patients with cancer of sense of security may result when the
the large bowel (Fig. 3 ).19 This poor course of ulcerative colitis is benign and
survival may be due to the associated indicates that such a course does not
colitis or to the young age of the pa preclude cancer20,21 and that the high
tients in our series. This finding con cancer risk in children in our series is
firms the poor prognosis of cancer when not owing to the fact that the patients
it complicates ulcerative colitis that be who were referred to us had more
gan during childhood.
severe disease.
The course of colitis was mild in most
The rarity of in situ carcinoma in
of the patients who were followed from an otherwise normal colon contrasts
childhood until they developed cancer. markedly, in our experience, with the
This does not necessarily mean that pa frequency of this finding in the presence
tients whose colitis runs a mild course of chronic ulcerative colitis. From this
are more prone to the cancer complica study, as well as in our experience with
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Fig. 2c
Fig. 2.—(a) Small cell carcinoma complicat
ing chronic ulcerative colitis. This lesion can
be mistaken lor malignant lymphoma (H & E
X 125). (b) Giant cell carcinomas comparable
to those seen in the thyroid gland represent
another vagary in the range of carcinoma com
plicating chronic ulcerative colitis (H & E X
350). (c) The incidence of carcinoma in situ
in grossly uninvolved stretches of colon in
creases sharply with the diligence of the search
for them. This grade 2 adenocarcinoma in situ
was discovered in one such “ normal” area (H
& E X 200).

Fig. 2b

ulcerative colitis beginning in adult life,
in situ carcinoma appears to represent
an intermediate stage between the com
monly observed mucosal hyperplasia
characteristic of the healing of the in
flammatory process, and the develop
ment of infiltrating colonic carcinoma.
In fact, at times it becomes difficult
or impossible to be certain where regen
erative or reparative epithelial changes
leave off and carcinoma in situ has its
beginnings. Indeed, multicentric carci
noma in situ is not infrequently discov
ered as a complication of long-standing
chronic ulcerative colitis.
However, it would appear that these
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TABLE VI.— Classification of C ancers by G rade (B roders’) and S ite of Occurrence
Grade

1

2

Site

1

4

9

Cases

Total cases
No.

%*

Ascending colon...................................
Transverse colon (including flexures)
Descending colon.................................
Sigmoid colon......................................
Rectum.................................................
Unknown..............................................

6
4
2
3
9
1

4
4
1
7
3
1

6
8
1
5
4
1

4
9
4
5
5
2

20
25
8
20
21
5

21
27
9
21
22
—

Total no................................................
% of 99 ................................................

25
25

20
20

25
25

29
29

99

100

*Based on 94 cancers for which the site was recorded.

malignant
transformations
require
years for their full development and be
cause of this we do not feel capable,
unlike Morson and Pang,22 of predict
ing from a biopsy of healing rectal m u
cosa which lesion will become m alig
nant. Thus, we believe prophylactic
proctocolectomy should be considered
when a child has had ulcerative colitis
for 10 years with involvement of the
entire large intestine.

Y e a r s a f t e r diagnosis of c a n c e r
Fig. 3.—Survival after the diagnosis o f can
cer: 77 patients in whom cancer developed as
a complication o f ulcerative colitis that had
begun in childhood compared with 15,388 pa
tients who had carcinoma o f the large bowel
not associated with chronic ulcerative colitis.
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R esum e
Les auteurs ont etudie un groupe de 77 malades qui souffraient de colite ulcereuse depuis
l’enfance et chez lesquels s’etait developpe un
cancer du colon. Chez 96% de ces malades,
le cancer etait apparu avant l’age de 40 ans.
Seulement 55% ont survecu six mois, 49%
ont survecu un an et 24% ont survecu cinq ans
apres la decouverte du cancer. Avant l’apparition du cancer, 55% des malades n’avaient que
peu souffert de la colite ulcereuse. Ces renseignements corroborent le risque de cancer deja
souligne chez des enfants atteints de colite
ulcereuse et viennent soutenir l’indication d’une
proctocolectomie prophylactique chez certains
de ces malades.

PROPRIETES IN H IB ITRICES DU SUC G ASTRIQU E H U M A IN
SUR L A SECRETIO N G ASTR IQ U E DU R A T :
D IFFEREN CE Q U A N T IT A T IV E ^ IN H IB IT IO N
SELON CINQ E T A T S PH YSIOPATH OLO GIQU ES*
MARCEL J. RHEAULT, M.D., M.Sc., F.R.C.S.[C], F.A.C.S.f
et LEON TETREAULT, M.D., M.Sc.,t Montreal, Que.
B r u n s c h w i g et ses collaborateurs ont
demontre dans une serie d’articles pu
blics de 1939 a 1943 16 que les secretions
gastriques humaines contenaient un facteur inhibiteur de la secretion gastrique.
Dans ces etudes, le sue gastrique etait
injecte par voie intra-veineuse a des
chiens porteurs d’une poche de Heidenhain. La secretion fundique, stimulee
par l’epreuve du repas, etait le plus inhibee lors de l’injection de sue gastrique

*Les auteurs ont ete subventionnes pour ce
travail par Le Conseil de la Recherche Medicale
du Canada (MA-2056).
fProfesseur adjoint de Clinique, Departement
de Chirurgie, Hotel-Dieu de Montreal, Univer
sity de Montreal, Montreal, Que.
tAgrege de Recherche (Pharmacologie), Uni
versity de Montreal, Directeur de l’Unite de
Recherche, Hopital St-Jean-de-Dieu, Montreal,
Que.

provenant de malades souffrant d’anemie pernicieuse: l’inhibition etait alors
de 8 0 % . Les sues de malades atteints de
cancer gastrique, accompagne d’achlorhydrie, provoquaient une inhibition de
l’ordre de 7 2 % . Une telle inhibition etait
beaucoup moins marquee avec des sues
de malades affliges d’hypochlorhydrie
idiopatique ( 3 6 % ) et les sues de sujets
normaux ( 2 4 % ) .
Menguy et Smith7 en 1960, sur une
preparation biologique experim ental
differente, soit le rat traite par la tech
nique de Shay, trouvaient des resultats
differents. Les injections de substances
inhibitrices avaient ete faites par voie
intra-veineuse. Les auteurs concluaient
que le malade porteur d’un ulcere duode
nal avait un sue gastrique plus inhibi
teur que le normo-secreteur et le porteur
d’un cancer gastrique.
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SUC GASTRIQUE HUMAIN

Dans le present travail, nous avons
utilise la technique de Shay chez le
rat et l’injection par voie peritoneale
d’extraits de sue gastrique humain provenant de malades atteints de diverses
pathologies: cancer gastrique, ulcere
gastrique, ulcere duodenal, anemie pernicieuse. Deux groupes temoins furent
de plus utilises: un premier recevant
des extraits de secretion gastrique venant de sujets normaux, le second ne
recevant aucune injection intra-peri toneale. Chaque malade nous a fourni
deux types de secretions: secretion obtenue dans des conditions basales et secre
tion aspiree apres stimulation par Histalog. Tous les resultats ont ete soumis a
des analyses de variance et de co-va
riance completees par des comparaisons
deux a deux.
M ateriel

et methodes

Collection du liquide gastrique
chez les patients
Un tube de Levin no 16 est installe
sous fluoroscopie. Pendant la duree de
la collection le patient ne doit pas avaler
sa salive. Pour etre acceptes, les speci
mens doivent etre libres de toute conta
mination par du sang ou de la bile.
Les collections sont divisees en deux
parties: (a) Collection nocturne: le
liquide gastrique nocturne est aspire
continuellement pendant 12 heures a
l’aide d’une succion mecanique. Son
volume est mesure et le specimen est
transfere dans un bocal place dans la
glace seche. (b) Collection apres stimu
lation a VHistalog: apres l’injection
sous-cutanee de 100 mg d’Histalog, les
prelevements de liquide gastrique sont
faits aux 15 minutes. Les secretions,
apres la mesure de leur volume, sont
aussi versees dans un bocal refrigere
par de la glace seche.
Tous les specimens sont conserves au
congelateur jusqu’au moment de leurs
traitements.
Dialyse
Les specimens sont degeles et centri
fuges a froid (4° C) durant deux heures
a 2500 rpm. Le surnageant est soigneu-
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sement decante dans des tubes a dialyse
Visking 10/32. La dialyse est effectuee
dans un bain d’eau courante durant 24
heures, puis les tubes sont transferes
dans un contenant d’eau distillee place
au refrigerateur ou la dialyse se poursuit durant 24 a 36 heures avec deux
ou trois changements d’eau.
Le contenu du tube de dialyse est
alors transfere dans des bouteilles a cen
trifuge et centrifuge durant deux heures
a 4° C. Le surnageant est decante (ou
filtre a travers un papier filtre What
man 42, si le liquide est trouble) dans
un ballon de lyophilisation.
Lyophilisation
Les specimens sont lyophilises et la
poudre obtenue est pesee immediatement et placee dans un petit contenant
de verre bien scelle. Us sont gardes dans
un dessiccateur au refrigerateur jus
qu’au moment de leur mise en solution
pour les dosages biologiques.
Dosages biologiques de I’activite
inhibitrice du sue gastrique
(technique de Shay)
Le rat anesthesie a Tether est pese,
sa temperature rectale prise et une laparotomie pratiquee. L ’estomac est expose,
le pylore ligature par un brin de soie,
puis la paroi est refermee par un surjet
en un plan total. Au moment de la su
ture, on injecte dans la cavite perito
neale le specimen de substance a etudier
(2 m g/m l/100 g de rats), dilue dans
un tampon phosphate de pH 7.5, 1.5N.
La technique bien executee se complete
en moins de cinq minutes. Les rats gar
des dans des cages individuelles pendant
quatre heures sont prives d’eau et d’aliments. Comme ils secretent continuelle
ment pendant la phase interdigestive, le
volume et 1’acidite de la secretion gas
trique sont des variables utiles dans
l’etude de substances inhibitrices ou stimulantes. Apres quatre heures, la tem
perature rectale est prise et les rats
sont sacrifies par ether. Une nouvelle
laparotomie est faite et une pince appliquee a la jonction oesophago-gastrique
pour prevenir le reflux et la perte de sue
gastrique. L’oesophage et le duodenum
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TAB LEAU I.— C onstitution des G roupes E xperimentaux
Diagnostic des sujets ou malades

Groupes experimentaux
Numero

Denomination

I

Temoin sans
traitement

II

Temoin

III

Anemie
pernicieuse

IV

Cancer
gastrique

V

Ulcere
duodenal

VI

Ulcere
gastrique

Traitement
IP

Nil

ayant fourni le sue gastrique*

—
Volontaires sains

Extrait de sue

gastrique

Anemie pernicieuse
Cancer gastrique
Ulcere duodenal

humain
Ulcere gastrique

*Chaque sujet ou malade a fourni deux echantillons de sue gastrique, le premier secrete pendant une periode
de jeune, le second secrete apres stimulation par Histalog.

sont sectionnes et le contenu de l’estomac vide dans une eprouvette graduee
qui est ensuite soumise a une centrifu
gation (2,000 rpm) pendant 15 minutes.
Le surnageant est decante, son volume
mesure, puis l’acidite totale est determinee par une solution d’hydroxyde de
sodium 0.5N a pH 7.5. La titration est
faite avec un appareil automatique radfometer; les resultats sont exprimes
en milliequivalents (mEq) par quatre
heures.
T r a it e m e n t d es d o n n ee s

Le travail a porte sur six groupes ex
perimentaux identifies par le diagnostic
des malades les constituant. Les sujets
humains malades ou volontaires sains
etaient des unites experimentales et a
chacun d’eux correspondait un groupe
de 20 rats constituant chacun des unites
d’echantillonnage. L’activite inhibitrice
des extraits de secretion gastrique de
chacun des malades fut ainsi dosee de
fa§on biologique grace a la secretion
gastrique de 20 rats differents. La cons
titution des groupes experimentaux est
exposee au tableau I. Le groupe temoin
sans traitement comprend cinq sousgroupes de 20 rats dont la secretion gas
trique a ete mesuree en l’absence de
tout traitement par extrait de sue gas
trique humain. Le groupe temoin est

compose de cinq sous-groupes de 20 rats
traites respectivement par des extraits
de sue gastrique provenant de cinq vo
lontaires sains. Le groupe anemie pernicieuse a pour unite experimental trois
malades souffrant de cette maladie et
pour unite d’echantillonnage 60 rats,
e’est-a-dire trois sous-groupes de 20 rats
traites par les extraits de sue gastrique
provenant de ces trois malades. II en
est de meme pour les groupes cancer
gastrique, ulcere duodenal et ulcere gas
trique. Les malades de ces groupes expe
rimentaux fournissent chacun du sue
gastrique dont les extraits sont titres
sur des sous-groupes de 20 rats.
Comme nous l’avons deja demontre8,
le poids des rats qui servent de dosage
biologique des inhibiteurs ou stimulants
de la secretion gastrique, est en corre
lation directe avec le volume total de
l’acidite de leur secretion gastrique. II
importe done de tenir compte de ces
poids lorsqu’on veut utiliser la secretion
gastrique du rat pour etudier l’influence
des extraits de sue gastrique humain.
Par l’analyse de variance, nous ne retrouvons aucune difference significative
entre les poids des animaux utilises pour
l’etude des six groupes experimentaux.
Malgre cette absence d’heterogeneite
significative puisque le poids des rats
est en correlation avec leur secretion
gastrique, nous avons utilise l’analyse

377

S U C G A S T R IQ U E H U M A IN

CVJ
oi
00
00

oi

^S £
<X0

a

R esultats

s

Influence des extraits de sue
gastrique humain sur le volume de la
secretion gastrique du rat (tableaux
II et III, fig. 1)

w
K
§

On retrouve une difference hautement significative lorsqu’on procede a
une comparaison simultanee des six
groupes. Les moyennes ajustees des
sommes de volume de secretion gastrique sont pour le groupe temoin sans
traitement de 87.0 ml, pour le groupe
temoin de 54.4 ml, pour le groupe anemie pernicieuse de 39.9 ml, pour le
groupe cancer gastrique de 46.9 ml, pour
le groupe ulcere gastrique de 53.7 ml.
A 1’analyse de covariance, le coefficient
de Fisher est de 13.18 et la probability
d’erreur de premier ordre est inferieure
a 0.001 (tableau II). Nous avons pousse
plus loin l’analyse en effectuant les 15
comparaisons deux a deux possibles
lorsqu’il existe six groupes (tableau
III). Par celles-ci il est clairement demontre (P < 0.001) que les extraits de
sue gastrique humain inhibent la secretion gastrique du rat. En effet, les comparaisons entre le premier groupe temoin sans traitement et chacun des cinq
autres groupes sont tres significatives
et fournissent des coefficients de Fisher
toujours superieurs a 20. Les extraits
de sue gastrique humain ont des pro
priety inhibitrices variables selon les

. ^£ I
to^§3

P<0.001

<
D
®
§
2
<
^
2
’«
«
^

F=13.18

de covariance pour eviter les erreurs
systematiques que pourrait introduire
la variation des poids entre les groupes.
Les donnees utilisees sont done les suivantes: la variable independante X est
la somme des poids corporels (g) des
20 rats utilises pour titrer l’extrait
gastrique de chacun des sujets ou malades constituant chacun des groupes
experimentaux; la variable independante Y est la somme des volumes (ml)
de secretion gastrique de ces 20 rats
ou encore la somme des acidites totales
(mEq) de ces 20 rats. Les donnees qui
caracterisent chaque unite experimentale sont done les sommes des donnees
de chaque sous-groupe de 20 rats correspondant a l’unite experimentale.

D

z

<
d

CD
CO

oc
s—
8S
i

w
§.
2
<
^
^

o
00

IX
s§
0 ) C r •-

g

S5S
||
O l. "

£
<
*
^
§

C

Sg

°l
S£

g

w
3
Z
l
'=:
<
2
£§
^

C

-ft.

s
O

TDa)
$2
aS

£
6,
M-C i
ca>n C l (•
CZi
i2s :
.5
W
cd :
Cai
<->j

cn

o ; v<d

v b

cC E
3
O>

Analyse de covariance

November 1972

378

Vol. 15

THE C A N A D IAN JOURNAL OF SURGERY

TABLEAU III.— I nfluence

des E xtraits de Sue G astrique H umain sur i.e V olume
G astrique du R at . C omparaisons D e u x a D eux

II Temoin

22.60681

VI Ulcfere gastrique

23.24621

0.0116

IV Cancer gastrique

24.19511

0.8716

0.7268

III Anemie pernicieuse

33.14061

3.0632x

2.6305

0.5085

V Ulcere duodenal

54.63621

6.1720*

5.6665*

1.2969

« P < 0.10
* P < 0.05
f P < 0.001

1
Temoin sans
traitement

II
Temoin

diagnostics des malades qui fournissent
ceux-ci. Les extraits de sue gastrique
provenant de malades souffrant d’anemie pernicieuse (P < 0.05) et demalades
souffrant d’ulcere duodenal (P < 0.10)
sont plus inhibiteurs que les extraits de
sue gastrique provenant de volontaires
sains. Les extraits de sue gastrique de
malades souffrant d’ulcere gastrique
ne sont pas significativement differents
des extraits de sue gastrique provenant
de temoins, mais sont significativement
moins inhibiteurs que les extraits prove
nant de malades souffrant d’anemie
pernicieuse (tableau III, fig. 1). Toutes
les autres comparaisons possibles entre
Somme de volumes
de secretion gastrique
(moyenne oiustee e" ml)

»
100 r

90h

Fig. 1.—Influence des extraits de sue gastri
que humain sur le volume de la secretion gas
trique du rat.

VI
Ulcere
gastrique

IV
Cancer
gastrique

de la

S ecretion

0.0502
III
Anemie
pernicieuse

l°s six groupes ne revelent aucune dif
ference statistique.
Influence des extraits de sue gastrique
humain ohtenus apres stimulation par
Histalog sur le volume de la secretion
gastrique du rat (tableaux IV et V,
fig. 2)

Deux types de sue gastrique furent
recueillis pour etude. Le premier dont
nous avons discute dans le chapitre pre
cedent est celui spontanement secrete.
Le deuxieme type dont nous avons fait
les extraits est celui obtenu apres stimu
lation de la secretion par Histalog. Les
extraits de ce deuxieme type de sue
gastrique furent etudies de la meme
faqon que les premiers. II existe une
difference hautement significative entre
les six groupes experimentaux; le coef
ficient de Fisher est de 6.71 et la proba
bility d’erreur est inferieure a 0.001
(tableau IV ). Les comparaisons deux a
deux demontrent encore clairement les
proprietes inhibitrices du sue gastrique
humain qui persiste quand la secretion
gastrique est stimulee par Histalog.
Tous les groupes sont significativement
inhibiteurs par rapport au groupe temoin sans traitement. Avec ces extraits
cependant, on ne retrouve plus aucune
difference entre les extraits de sue gas
trique obtenus des malades souffrant de
differentes pathologies (tableau V,
fig. 2).
Influence des extraits de sue gastri
que humain sur I’acidite totale de la
secretion gastrique du rat (tableaux
VI et VII. fig. 3)

-J-

v

v

y

I nfluence

v

V

;

des

E xtraits

4.

de

V

~

^

t

v

V

r

Nombre d ’unites experimentales = n (nombre de malades)
Nombre d ’unites d ’echantillonage = R (nombre de rats)
Moyenne des sommes de
poids corporel (g) = Xj.

I
Temoin sans
traitement

II
T emoin

© w.
3 £ fD
2 cc
—W
CO' ft
93 “„ cf
X
C/2 ST. ^

^

JO

Volume

de la

S ecretion

IV
Cancer
gastrique

V
Ulcere
duodenal

VI
Ulcere
gastrique

6

6

5

5 X 20

5 X 20

2 X 20

6 X 20

6 X 20

5 X 20

2

1819.2

1828.2

1869.0

1816.2

2126.5

1816.6

Moyenne des sommes de
volumes de secretion gas
trique (ml) = Y j.

86.2

49.6

43.4

45.9

50.2

44.1

Moyenne ajustee des sommes
de volumes de secretion gas
trique (ml) = Y;.

88.2

51.3

44.0

47.9

43.1

46.1

F = 6.71

P < 0.001

' ABLEAU V.—I nfluence des E xtraits de Sue G astrique H umain Obtenu apres
S timulation par H istalog sur le Volume de la S ecretion G astrique du R at.
Comparaisons D eux A D eux
II Temoin

16.1075f

IV Cancer gastrique

20.9173f

0.1453

VI Ulcere gastrique

20.9216f

0.3142

0.0417

III Anemie pernicieuse

13.1913*

0.3624

0.1116

0.0318

V Ulcere duodenal

22.1576f

0.7377

0.2750

0.1002

0.0049

1
Temoin sans
traitement

II
IV
Temoin Cancer
gastrique

VI
Ulcere
gastrique

III
Anemie
pernicieuse

o ST.<t>
3 § m
* P — 0.01
t P — 0.001
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Donnees caracterisant les groupes de 20
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respond Tun de ces groupes.
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TABLEAU VII. - I nfluence des E xtraits de Sue G astrique H umain sur L’Acidite
I otale de la S ecretion G astrique du R at. C omparaisons D eux A D eux
11 Temoin

24.4505f

VI Ulcere gastrique

27.2044f

0.0992

IV Cancer gastrique

26.8757f

1.0825

0.6117

III Anemie pernicieuse

34.2093f

2.8350

1.9295

0.3228

V Ulcere duodenal

58.6857f

6.5369*

4.9989*

1.1855

I
Temoin sans
traitem ent

II
Temoin

VI
Ulcere
gastrique

IV
Cancer
gastrique

0.1215
III
Anemie
pernicieuse

I

Ctf q;

CO g 3

* P <0.05
f P <0.001
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TABLEAU VI.—I nfluence

des

E xtraits

de

Sue G astrique K umain

sur

I
Temoin sans
traitement

Groupe

L’Acidite T otale
II
Temoin

de la

III
Anemie
pernicieuse

S ecretion G astrique

du

R at

IV
Cancer
gastrique

V
Ulcere
duodenal

VI
Ulcere
gastrique

5

5

3

3

6

5

5 X 20

5 X 20

3 X 20

3 X 20

6 X 20

5 X 20

1819.2

1846.6

1662.7

1969.7

1889.2

1891.2

Moyenne des sommes
_
d ’acidite totale (mEq) = Y j .

10.4

6.1

3.8

5.3

4.0

5.9

Moyenne ajustee des sommes
d ’acidite totale (mEq) = Vi.

10.5

6.1

4.3

5.0

3.9

5.8

Nombre d’unites experimentales = n (nombre de malades)
Nombre d’unites d ’echantillonnage = R (nombre de rats)

Donnees caracterisant les groupes de 20
rats. A chaque unite experimentale cor
respond 1’un de ces groupes.

Moyenne des sommes de
poids corporel (g) = Xi.
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Les resultats de ce travail demontrent
1’existence d’un facteur gastrique in
hibiteur de la secretion gastrique avec
une probability d’erreur inferieure a
0.001. Cette etude confirme done les
conclusions de Brunschwig, Menguy et
leurs collaborateurs.
Des les premieres publications sur
1’existence de proprietes inhibitrices de
sue gastrique humain, on a fait etat de
differences quantitatives entre les pouvoirs inhibiteurs des sues gastriques de
malades souffrant de pathologies diverses.1'7 De plus, selon les dosages biologi-
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Le sue gastrique humain quand la
secretion est stimulee par Histalog a
sur I’acidite totale de la secretion gastri
que du rat les memes effets que sur le
volume de cette secretion. La comparai
son simultanee des six groupes produit
un coefficient de Fisher tres significatif
(P < 0.001, tableau VIII) et le sue
gastrique humain a des proprietes inhitrices tres claires (P < 0.001, tableau
IX ). Aucune difference statistique n’est
retrouvee pour les neuf autres compa
raisons possibles entre les groupes
experimentaux.

oCM

LO

=

Influence des extraits de sue gastrique
humain obtenus apres stimulation par
Histalog sur I’acidite totale de la
secretion gastrique du rat (tableaux
VIII et IX, fig. U)

a

'B

5 .2

Les effets des extraits de sue gastrique sur 1’acidite totale de la secretion
gastrique du rat sont comparables a
ceux obtenus sur le volume des secre
tions gastriques. La comparaison simultanee des six groupes est significative
(F = 14.05, P < 0.001, tableau VI) et
les comparaisons deux a deux demontrent le pouvoir inhibiteur du sue gas
trique humain (P < 0.001, tableau
VII). Les extraits de sue gastrique de
malades souffrant d’ulcere duodenal
sont significativement plus inhibiteurs
que les extraits de sue gastrique provenant de volontaires sains ou de ma
lades souffrant d’ulcere gastrique (P
< 0.05, tableau VII, fig. 3).
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TABLEAU IX .— I nfluence des E xtraits de Sue G astrique H umain Obtenu apres Stimulation par
H istalog sur l ’acidite T otale de la S ecretion G astrique du R at. C omparaisons D eux a D eux
II Temoin

21.0177*

VI Ulcere gastrique

24.6525*

0.1447

IV Cancer gastrique

26.4925*

0.1283

0.0015

V Ulcere duodenal

29.9461*

1.1596

0.4980

0.5956

III Anemie pernicieuse

21.8013*

1.4601

0.8470

0.9450

0.1306

VI
Ulcere
gastrique

IV
Cancer
gastrique

V
Ulcere
duodenal

I
Temoin sans
traitement

II
Temoin

* P < 0.001

ques utilises e t les especes anim ales en de la technique de Shay proposent un
cause, l’o rd re de puissance inhibitrice ord re decroissant d iffe re n t: ulcus duo
des sues g a striq u e s d’un e ta t pathologi- denal en prem ier lieu, puis su je ts norque a l’a u tre varie. Avec la technique de m aux et enfin cancer de l’estom ac. Les
la poche de H eidenhain, chez le chien, diverses techniques de p rep a ra tio n de
l’injection intra-veineuse de substances l’e x tra it, les voies d’ad m in istratio n va
in h ib itric e s obtenues p a r precip itatio n riables et les dosages biologiques diffea l’alcool, indique que le pouvoir inhi- re n ts expliquent peut-etre ces conclu
b ite u r du sue gastrique est le plus m a r sions en p a rtie contradictoires. Il reste
que d an s 1’anem ie pernicieuse; il Test aussi fo rt possible qu’il ne s’agisse enfin
m oins d an s le cancer g astrique et il est que de fluctuations d’echantillonnage
au plus bas chez les su je ts norm aux.1"5 qui n ’a u ra ien t pas ete controlees p ar les
Les a u te u rs qui se sont servis du r a t et m ethodes statistiques appropriees.
Dans la presente experience, que Ton
considere le volume de secretion g a s tri
Somme d 'a c id it e t o t a l*
de s e c r e tio n g a s tr iq u e
que des r a ts ou leur debit d’acide, la
< m o ye n n * o ju s te e en m Eq)
com paraison sim ultanee des six groupes
dem ontre to u jo u rs une heterogeneite si
gnificative, a u ta n t avec les e x tra its de
sue g astrique de base qu’avec les ex
tra its de sue gastrique obtenus apres
stim ulation p a r H istalog. Avec les deux
types de m esures, volume et debit acide,
les e x tra its de secretion g astriq u e hum aine, qu’ils viennent de m alades ou de
su je ts norm aux, ont tou jo u rs un pou
voir in hibiteur h autem ent significatif.
On retrouve en e ffet tou jo u rs une inhi
bition h autem ent significative pour les
e x tra its de sue gastrique hum ain p ar
com paraison avec les secretions de ra ts
tem oins ne recevant aucun tra ite m e n t.
La recherche des differences en tre les
pouvoirs inhibiteurs de sue de m alades
so u ffran t de diverses pathologies n ’a
pas donne de resu lta ts sig n ificatifs lorsF ig. 4.—Influence des ex tra its de sue g a s tri que les secretions hum aines ont ete ob
que hum ain obtenus apres stim ulation p a r His- tenues apres stim ulation p a r Histalog,
tolog su r l’acidite totale de la secretion g a s
que le volume ou le debit d’acide des setriq u e du ra t.
san s
tr a ite m e n t

p e rn ic ie u s e g a s tr iq u e d u o d e n a ! g a s tr iq u e
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cretions de ra ts fu sse n t pris comme va
riable de m esure. 11 nous semble logique
de conclure que 1’utilisation de secre
tions basales serait plus efficace que l’utilisation de secretion g astrique obtenue
a p res stim ulation pharm acologique dans
la recherche du pouvoir in h ib iteu r d’extr a its de diverses secretions gastriq u es.
II en est to u t a u tre m e n t avec les e x tra its
de sue gastrique obtenus dans des condi
tions basales. En u tilisa n t le volume
comme variable, la puissance inhibitrice
des sues gastriques hum ains va decrois
sa n t selon l’ordre su iv an t: ulcere duo
denal, anemie pernicieuse, cancer g a s tri
que, ulcere gastrique, tem oins norm aux.
Cet ordre ne peut cependant e tre e x tr a 
pole a l’ensemble des populations m alades. Seules trois com paraisons deux a
deux sont statistiq u em en t significatives: dans 1’ulcere duodenal et dans l’anem ie pernicieuse les secretions g a striq u e s
sont plus inhibitrices que celles du su je t
sain ; chez l’anemique, ce pouvoir inhi
b ite u r est plus m arque que chez le m alade qui souffre d’ulcere gastrique. En
u tilisa n t des p reparations biologiques
differentes, B runschw ig d’une p a rt a
deja dem ontre le pouvoir plus in h ib ite u r
du sue gastrique de m alades s o u ffra n t
d’anem ie pernicieuse, M enguy d’a u tre
p a rt a deja aussi f a it une observation
semblable pour le sue de m alades souf
f ra n t d’ulcere duodenal.
Si le debit acide des secretions g a s tr i
ques du r a t est utilise comme param etre , on retrouve le m em e ordre decrois
sa n t des pouvoirs inhibiteurs du sue g a s 
triq u e que celui deja decrit pour le volu
me des secretions gastriques. Comme
precedem m ent, le sue des p atien ts a y a n t
un ulcere duodenal e st plus in h ib ite u r
que le sue des tem oins e t le sue de ceux
qui souffrent d’ulcere gastrique. On ne
retro u v e plus par contre de difference
significative entre les anem iques e t les
tem oins.
R esu m e

Les proprietes inhibitrices du sue g a s 
triq u e hum ain sur la secretion g a s tr i
que de ra ts ont ete etudiees chez cinq
groupes de su je ts: su je ts tem oins n o r
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m aux, m alades s o u ffra n t d’ulcere duo
denal, d’ulcere g a striq u e , de cancer g a s
triq u e e t d ’anemie pernicieuse. Ces p ro 
p rietes inhibitrices o n t ete dem ontrees
avec une probability d ’e rre u r in fe rie u re
a 0.001 a u ta n t s u r le volume de secre
tion que s u r le debit acide to tal. Les sues
g a striq u e s hum ains o b tenus sans stim u 
lation o nt des pouvoirs in h ib ite u rs significativem ent v a ria b le s selon les differe n ts e ta ts physiopathologiques etudies. Ces differences sta tis tiq u e s ne sont
plus retrouvees lo rsq u ’on u tilise le sue
g astriq u e hum ain obtenu p a r stim u la
tion avec H istalog.
B ib l io g r a ph ie
1. B r u n s c h w ig

A,

Clarke

TH,

van

P ro-

J, et a l: Secretory depressant in
achlorhydric gastric juice of patients
with carcinoma of stomach. Surg Gy
necol Obstet 70: 25, 1940
2. Idem,'. Gastric secretory depressant in ex
tracts of achlorhydric carcinomatous
stomachs. A nn S u rg 113: 41, 1941
3. B r u n s c h w ig A, R a s m u s s e n RA, C a m p EJ,
et a l: Gastric secretory depressant in
gastric juice. S u rgery 12: 887, 1942
h a sk a

4. B r u n s c h w ig A,

S c h m it z

R, R a s m u s s e n

RA: Experimental observations on
achlorhydria of gastric cancer. J N atl
Cancer Inst 1: 481, 1941
5. B r u n sc h w ig A, v a n P r o h a sk a J , C la r k e

TH, et a l: Secretory depressant in gas
tric juice of patients with pernicious
anemia. J Clin Invest 18: 415, 1939
6. S cott VB, M oe R, B r u n s c h w ig A: Fur
ther studies on properties of gastric
secretory depressant in gastric juice.
Proc Soc Exp Biol Med 52: 45, 1943
7. M en gu y R, S m it h W O : Inhibition of g a s 
tric secretion in rat bv normal and
abnormal human gastric juice. Proc
Soc E xp Biol M ed 105: 238, 1960
8. R h e a u lt M J, D e s c h e n e s J , T etr ea u lt L :

Demonstration chez le rat d’un “facteur” gastrique inhibiteur de la secre
tion gastrique. Can J Surg 13: 288 1970

Summary
The property of human gastric juice to
inhibit gastric secretion in the rat has been
studied using, as a source of the material, five
different groups: normal controls, patients
suffering from duodenal and gastric ulcers,
gastric carcinoma and pernicious anemia.
The inhibition of the volume as well as the
acid output of the rats’ gastric secretions was
demonstrated with a probability of error of
less than 0.001.
The human gastric juice obtained without
stimulation produces inhibition which varies
significantly from one disease to another.
These differences are no longer valid when
Histalog-stimulated human gastric juice is
used.
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SPHINCTEROPLASTY, AN INDIVIDUALIZED OPERATION:
AN ANATOMIC STUDY IN AUTOPSY MATERIAL
W . GORDON B E A T TIE , M.D., F.R .C .S.[C ], F.A .C .S.‘ and
M. KUP P U SA M I, M.D., C.R .C.S.[C], Ottawa, Ont.
E a r l y in this century many surgeons
studied the choledochoduodenal region
and particularly the ampulla of Vater,
in a search for the cause of pancreatitis.
More recently the problems posed by re
tained common duct stones and chronic
pancreatitis have continued to challenge
surgical investigators working in this
area.
Opie in 190U demonstrated the roh
of bile in experimental pancreatitis and,
at autopsy, demonstrated pancreatitis in
a subject with an obstructed ampulla
due to a small stone. He suggested that
bile refluxing into the pancreas caused
the pancreatitis. Archibald,2,3 studying
models of experimental pancreatitis,
concluded that the cause was spasm of
the sphincter of Oddi and suggested
that the sphincter be sectioned to treat
certain patients with pancreatitis. He
was the first surgeon to do a sphinc
terotomy. Archibald also drew attention
to the work of Oddi, who clarified the
anatomy and physiology of the sphinc
ter that guards the entrance of the
common duct into the duodenum.3 In
1937 Doubilet and Colp4 demonstrated
that the sphincter of Oddi resists the
flow of bile. Later, Doubilet and Mul
holland3, 6 applied sphincterotomy to the
treatment of recurrent pancreatitis.
Ochsner, commenting on Doubilet’s
presentation in 1948, suggested that the
ductal mucosabe sutured to the duodenal
mucosa to prevent stricture formation.
McPhedran et al.7 studied the histology
•of the ampulla and confirmed the pres
ence of fronds of duodenal mucosa
hanging into the lumen of the ampulla
originally described by Fatselt.8 Al
though these fronds may assist in pre
venting reflux, they act more as a one
way valve than as a cause of resist
ance to flow of bile into the duodenum.
In 1959 Eiseman et al.’ proved ex* Professor of Surgery, University of Ottawa;
■Chairman, Division of Surgery, Ottawa Civic
Hospital, Ottawa, Ont.

perimentally and clinically that sphinc
terotomy does not permanently lower
resistance to fluid flow through the am
pulla of Vater. Boyden10 precisely de
fined the length of the choledochal
sphincter in man and demonstrated that
sphincterotomy, as described by Dou
bilet and Mulholland, did not lower the
resistance to bile flow through the am
pulla because it did not cut all the
sphincter. To eliminate the sphincter’s
action completely, Jones et al.nls per
formed sphincteroplasty. They divided
all the muscle, removed a wedge of ampullary wall and precisely opposed com
mon duct to duodenal mucosa to prevent
leakage. Bartlett and Nardi18 described
a similar operation, though they named
it “ transduodenal sphincterotomy” . In
addition, they sectioned the septum
dividing the pancreatic duct and bile
duct. Vajcner, Grossling and Nicoloff17
demonstrated the permanent effect of
their sphincteroplasty, an operation es
sentially the same as that of Jones.
Serious complications such as duo
denal leak or pancreatic injury may
occur with extended section of the
sphincter if the length of the sphinc
teroplasty extends beyond the duodenal
wall. We carried out the study described
below to determine the anatomic vari
ables that govern sphincteroplasty.
M aterial and M ethod

In 54 subjects coming to autopsy the
intramural course of the common bile
duct was studied, noting the length (ex
tent) of the sphincter, direction of duct
and its relation to the pancreas. We did
the 1-cm. incision sphincterotomy of
Doubilet and Mulholland and the more
extensive sphincteroplasty of Jones; the
latter was modified in the light of
knowledge gained as the study pro
gressed.
The technique of sphincteroplasty
was as follow s: the duodenum was fully
mobilized to its embryonic midline posi-
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tion and rotated anteriorly. The papilla
was incised on its most lateral aspect in
the 11 o’clock direction. The transition
line where the pink mucosa of the
sphincter met the yellow honeycombed
mucosa of the bile duct within the wall
of the duodenum indicated the proximal
end of the sphincter. The length of the
incision could then be determined pre
cisely. No wedge of sphincter or mucosa
was removed.
At autopsy in five cases the effects
of these procedures were correlated
with radiographs of common-duct drain
age obtained by injecting barium into
the common duct before and after the
specific operative procedures.
A

n a t o m ic a l

O b s e r v a t io n s

In all 54 autopsy specimens the bile
and pancreatic ducts opened into the
duodenum through the duodenal papilla,
situated on the concave side of the sec
ond part of the duodenum an average
of 9.1 cm. (7.5 to 12 cm.) from the
pylorus. The average length of the pa
pilla (7.5 mm.) did not correlate with
the length of its sphincter.
In its retropancreatic course, the
common bile duct is buried in the head
of the pancreas and covered posteriorly
by a thin layer of pancreatic tissue. At
its distal end the duct inclines slightly
anteriorly and opens at the posterior

Fig. 1.—Pancreatic head turned anteriorly
(with Kocherized duodenum removed).

part of the pancreatic surface of the
duodenum. In Fig. 1 the pancreatic
head is turned anteriorly as in a fully
mobilized duodenum, with the duode
num removed; the figure shows the
ampullary end of the common duct as
it lies in the posterior part of the duo
denal sulcus of the pancreatic head.
Thus, as visualized during operation,
the ampulla is directed interiorly and
slightly anteriorly in the 11 o’clock posi
tion. The pancreatic duct opens on the
intramural portion of the medial w^all
of the ampulla.

Tig- 2.—Opened common duct and sphincteric area. Note the abrupt transition zone.

386

Vol. 15

T H E C A N A D I A N J O U R N A L OF S U R G E R Y

P A N C R E A T I C TI SS UE

Fig. 5.—Identification of structure shown in
Fig. 4.

Fig. 3.—Length o f the intramural common
duct and sphincter of Boyden.

The sphincteric area is thicker than
the rest of the common bile duct wall as
can be seen in the longitudinally opened
common duct (Fig. 2). The area pre
sents a smooth pink appearance in con
trast to the slightly yellowish honey
combed surface of the mucosa of the
common duct. There is an abrupt transi
tion at this junction, which helps to
identify the proximal limit of the
sphincter when examining the open
duct.

F ig. 4.—Low-power microscopic section of
Boyden, duodenal wall and pancreas.

The length of the intraduodenal por
tion of the common bile duct averages
16 mm. (10 to 23 mm.), being slightly
longer (1 mm. average) than the full
length of the sphincter of Boyden which
averages 15 mm. (10 to 20 mm.) (Fig.
3). On microscopic examination the
sphincter muscle always lies within the
duodenal wall (Figs. 4 and 5). Pancre
atic tissue lies adjacent to the duodenal
wall near the common bile duct entrance
and thus is vulnerable to inadvertent
injury from a sphincterotomy incision
that extends beyond the upper limit of
the sphincter (Fig. 5).

the

intramural

common

duct,

sphincter

of
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In all five autopsy cases the sphincter
was demonstrated to be competent by
barium x-ray studies before the muscle
was sectioned. Therefore we could make
a gross assessment of the effects on
sphincteric competence of sphinctero
tomy and sphincteroplasty. Following
routine sphincterotomies the radio
graphs clearly demonstrate the persist
ently narrowed segment of the lower
end of the common duct within the duo
denal wall (Fig. 6). Films made after
sphincteroplasty (Fig. 7) show that the
diameter of the bile duct as it opens into
the duodenum is increased and now al
most equals the diameter of the com
mon duct itself.
Sum mary

Fig. 6.—Barium x-ray of common duct after
sphincterotomy.

and

C o n c l u s io n

The intraduodenal course of the com
mon bile duct was studied in 54 autopsy
cases. It was demonstrated that ade
quate sphincteroplasty can be tailored
to the individual patient. This is at
tained by noting the extent of the
sphincter of Boyden, precisely identi
fied by the junction of the smooth pink
mucosa overlying the sphincter and the
yellowish honeycombed mucosa of the
lower end of the common duct. The
junction always lies within the duodenal
wall. Limiting the extent of the incision
to this landmark lessens the possibility
of duodenal leak and injury to the
pancreas. In autopsy specimens sphinc
teroplasty proved to be superior to
sphincterotomy in providing the widest
diameter at the lower end of the com
mon duct.
The authors would like to thank Dr. M. O.
Klotz for his co-operation in providing un
limited access to the autopsy material. Our
appreciation is also expressed to Mrs. M. Clark
for secretarial assistance.
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R esum e
Les auteurs ont eu l’occasion d’etudier l’anatomie de la region choledocho-duodenale au
cours de 54 autopsies. Cette region est d’une
importance toute particuliere pour le chirurgien soucieux d’eviter les problemes de la pancreatite et des calculs choledociens. Ils ont demontre qu’il est possible de modifier la sphincteroplastie pour l’adapter aux besoins de chaque malade. Ils font remarquer qu’il est facile
de mesurer avec precision la longueur du
sphincter de Boyden, grace a la jonction de la
muqueuse rosatre recouvrant le sphincter avec
la muqueuse jaunatre alveolee de la portion
inferieure du choledoque. Cette jonction siege
toujours au sein de la paroi duodenale. En limitant l’incision a ce repere, on reduit ipso
facto le risque de suintement duodenal et de
lesion au pancreas.
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CLINICAL TRIAL OF A NEW ABSORBABLE SYNTHETIC
SUTURE MATERIAL: POLYGLYCOLIC ACID*
P R A N K W. TU R NER , M.B., Ch.B., M.Sc., F.R.C.S.[C], F.A .C .S.,
W ILLIA M A. GRISWOLD, B.Sc., M.D., H ER BERT W . JA N ZE N , M.Sc., M.D.,
JOHN F. M ILNER, B.Sc., M.D. and LEONARD F. RIVERS, B.Sc., M.D.,
Edmonton, Alta.

A n ideal suture must be strong enough
to maintain the tissues in apposition
until sufficient collagen has been laid
down to provide an intrinsically strong
wound. Thereafter, because the suture
is not needed and its continued presence
may be harmful, natural dissolution is
advantageous. While the suture is pro
viding strength to a wound, it should in
terfere as little as possible with wound
healing. It should not provoke a foreignbody response and should occupy little
space. From the practical viewpoint the
suture material should be easy to handle
and, when knotted, the knots should
remain secure. The hospital administra
tor will expect it to be cheap and to have
a long shelf life.
Until recently none o f the available
suture materials met these demands.
Some of the newer synthetic materials
provide great strength and relative tis
sue inertness but are not absorbed. In
fact the only successful absorbable su
ture, catgut, has been in use since the
time of Galen.1 Unfortunately catgut
varies widely in its strength and ab
sorbability, and frequently causes an
intense local tissue reaction.
A new synthetic absorbable suture
material, a polymer of glycolic acid, is
now available which is said to combine
the qualities of strength, tissue inert
ness and absorbability while being easy
to handle. The present study was insti
tuted to test the validity of these claims.
S u t u r e M a t e r ia l

Polyglycolic acid (PGA) t is the homo
polymer of glycolic acid (hydroxyacetic
acid). The suture made from it is non
toxic, non-collagenous and absorbable.
•From the Division of General Surgery, De
partment of Surgery, University of Alberta
Hospital, Edmonton, Alta.
fDexon, supplied by Cyanamid of Canada
Limited (Davis & Geek), Montreal, Que.

It appears to have several advantages
over catgut yet retains many of the
desirable features o f a non-absorbable
suture. This synthetic polymeric fibre
has the unique property of predictable
progressive absorption. The polyester is
extruded to form continuous filaments
which are then braided into sutures of
different diameters. It possesses a
“ straight pull” tensile strength o f 77,800 psi, superior to that of catgut
(54,600 psi), silk (62,400 psi), and cot
ton (48,000 psi), but less than that of
Dacron (115,000 psi). However, its
“ knot-pull” tensile strength is equiva
lent to that of Dacron and superior to
that of silk, cotton and catgut.1
In animal studies PGA sutures have
had greater strength than catgut at
seven and 11 days but the values were
substantially similar at 15 days. The
time required for complete absorption is
similar to catgut— approximately 60
days.1,2 Tissue reaction is consistently
less with PGA than with catgut.1'4 In
studies in both rabbits and dogs, PGA
did not interfere with the normal pro
cess of wound healing. The breaking
strength of tissues sutured with PGA
and an equivalent size of catgut was
similar in both rabbits and dogs.1' 2
In metabolic studies, 14C-labelled PGA
was completely absorbed from the im
plantation site by 128 days. The 14C label
was recovered principally from the
urine and expired air. There was no in
dication of selective concentration in
any one site.2 Toxicity studies using 80
times the equivalent amount that might
be left in a patient after operation have
been entirely negative. Teratologic stud
ies in rabbits have not demonstrated
any effect on the mother, fetuses or on
the incidence of malformation.
In previous clinical studies wounds
have healed well and most investigators
report that PGA is extremely strong,
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easy to handle and produces minimal
reaction.4'7
P resent

stu d y

A clinical trial was done in the Uni
versity of Alberta Hospital, Edmonton,
Alberta, to obtain first-hand experience
with this suture and to add to the num
ber of controlled studies.
The suture was used only in patients
undergoing elective surgery and an in
formed consent was obtained from all of
them. Because the effect of gastroin
testinal secretions (saliva, gastric juice,
bile, pancreatic juice, succus entericus)
on PGA is unknown we did not place
sutures in contact with these fluids,
and we did not use it in pregnant wom
en or in children.
Because clinical studies of wound
healing are difficult enough without in
troducing unnecessary variables, pa
tients with local or systemic disease
that might complicate wound healing
were excluded, for example those re
quiring large amounts of corticosteroids,
those in advanced uremia and those who
had previously undergone local irradia
tion to the operative site. We included,
however, those with the common haz
ards of obesity, chronic cough and
malignant disease.
Thirteen members of the general
surgical staff participated in this study
and used the suture on a trial basis.
M ethod

The resident on the surgical service
allotted 200 patients to either the ex
perimental or the control group on an
alternate basis. We considered this sat
isfactory because the choice of suture
material was not dictated by clinical
factors.
In patients in the experimental group
only PGA suture or ligature material
was used throughout. In the control
group the surgeon used his customary
suture material or combination of ma
terials— other than PGA. He retained
the right to use materials other than
PGA in the experimental group if he
thought this necessary. If he did, the
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patient was removed from the study.
The suture was evaluated from three
aspects.
(1) The patient and his wound were
evaluated where possible at 24 hours,
five to seven days and six to eight weeks
postoperatively. Patients failing to
attend for the six- to eight-week exami
nation were dropped from the study.
Particular attention was paid to the pro
gress of wound healing, e.g. the pres
ence or absence of edema, cellulitis,
suppuration, seroma, hematoma and a
healing ridge. In a general way some
attempt was made to determine marked
deviations from normal in pain and rate
of healing.
(2) An attempt was made to deter
mine any unusual systemic response.
Because Morgan7 had demonstrated an
occasional unexplained elevation of
SGOT after the use of PGA we meas
ured this enzyme before and after op
eration in all patients. In addition the
leukocyte count, sedimentation rate and
electrophoretic pattern of serum pro
tein were measured before and after.
(3) At the conclusion of the study
the 13 surgeons completed a question
naire concerning the strength of the su
ture, the reaction it produced in tissues,
its absorbability and its handling qual
ities. They were asked specifically about
its knot-tying properties and the
amount of tissue drag. (Tissue drag
refers to the ease with which the suture
slides through tissues.)
R esults

Two hundred patients entered the
study. Fifteen were lost to follow-up
and were excluded. Eight were dropped
from the study because the surgeon used
a mixture of PGA and conventional
sutures. Two were lost because of in
complete records and one was excluded
because she had received irradiation to
the wound before operation.
Of the 174 patients available for
analysis, 90 had been exposed only to
PGA. Eighty-four patients served as
controls; in these the surgeon used his
own choice of suture material excluding
PGA. Table I shows the procedure per-
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TABLE I.— A llocation
E xperimental (PGA)

of
and

P atients
C ontrol

to

the

G roups

PGA
Control
No. of patients No. of patients

Procedure
Cholecystectomy
Appendectomy
Breast biopsy
Varicose veins
Head and neck
operations
Herniorrhaphy

35
2
21
17

33
1
16
17

9
6

5
12

Total

90

84

formed and the distribution between the
experimental and the control groups.
The discrepancies in patient distribu
tion between the two groups are the
result of rejection of patients for the
reasons given above, e.g. in many pa
tients undergoing herniorrhaphy the
surgeon would not use an absorbable
suture.

Among the control patients two had
stitch abcesses; one o f them had mul
tiple abscesses at the site of catgut su
tures.
None of the PGA patients developed
seromas although three of the control
patients did. Three PGA patients devel
oped hematomas— one, at the site of a
breast biopsy, required evacuation and
resuturing 24 hours later. Two control
patients developed hematomas and one
of these after a cholecystectomy had to
be evacuated in the ward. The other
hematomas in both groups were minor
and did not interfere with wound heal
ing.
Four PGA patients and three controls
developed hypertrophic scars at six
weeks.
TABLE III.— A lterations in L aboratory P ara 
meters Observed in the PGA and the C ontrol
G roups S ix W eeks A fter O perations

W o u n d H e a l in g

PGA

The wound complications were sim
ilar in the two groups (Table II). Two
wounds became infected in both the
PGA and the control groups. In the
PGA group one was a small stitch abcess about a suture that had been left in
the skin for 12 days. The second infec
tion developed in an obese patient with
a recurrent leiomyosarcoma of the ute
rus and an incisional hernia. The sur
geon did a keel type of repair but the
wound became infected and broke down.
TABLE II.— I ncidence
in

the

of W ound C omplications
E xperimental (PGA) and C ontrol
G roups

Complication
Infection............................
Seroma..............................
Hematoma........................
Dehiscence........................
Incisional hernia....... / . . .
Hypertrophic scar. . / . . . .
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PGA
2
0
3
1
1(?)
4

Control
2
3
2
0
0
3

Total no. of complications
Total no. of patients........

10*
90

10
84

Overall percentage of
wound complications.......

11%

12%

*One patient appears twice—an infected wound
which subsequently dehisced.

No. with unexplained ele
vation in leukocyte
count (>10,000/c.mm.)
No. with unexplained ele
vation in sedimentation
rate ( > 15 mm. in one
hr.).....................................
No. with unexplained ele
vation in SCOT (> 50
units/ml.)..........................

Control

7

5

14

8

4

5

We found no evidence that PGA al
tered the rate of wound healing or pro
duced a less painful wound, but con
sistently there was less reaction in
wounds sutured with PGA. The absence
of edema and erythema around the ma
terial was quite remarkable.
Systemic Response (Table III)
At the six-week follow-up seven pa
tients in the PGA group and five pa
tients in the control group had leukocyte
counts between 10,000 and 15,000/c.mm.
All had had normal leukocyte counts
before operation. In none was there an
obvious cause.
Fourteen patients in the PGA group
and eight patients in the control group
who had normal preoperative sedimen
tation rates had rates of greater than 15
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mm. in one hour at the six-week exami
nation. In none of these patients was
there an obvious explanation.
Four patients in the PGA group and
five controls who had normal preopera
tive levels had an SCOT greater than 50
units/ml. at six weeks. Again there was
no obvious cause and in none did the
SGOT exceed 150 units/ml.
None of the patients in either group
had detectable changes in the protein
electrophoretic pattern.
Evaluation of the Suture Material
by the Participating Surgeons

Of the 13 participating surgeons, two
had no experience with the suture and
one was too involved with the study to
express an unbiased opinion. This as
sessment is therefore based on the
opinion of 10 surgeons.
All 10 agreed that PGA suture had
strength that was more than adequate.
Five believed that the tissue reaction
to PGA was less than to catgut. Two
considered the reaction to be about the
same. Three were unwilling to express
an opinion.
Since no one reopened a wound that
had been closed with PGA, none could
express an opinion concerning its ab
sorbability.
Six surgeons considered the knottying properties of PGA to be inferior
to those of catgut. However, two be
lieved it to be equivalent and two more
considered that PGA was superior.
Seven surgeons felt that PGA produced
more tissue drag than catgut, two felt
it was about the same, and one was
unwilling to express an opinion.
Three of the 10 surgeons said that
they would not continue to use the su
ture routinely in its present form, be
cause its handling properties and
knot-tying qualities were inferior or
because the suture offered no advantage
over catgut.
The surgeons were asked particularly
to compare PGA and catgut because it
is the latter that PGA is designed to
replace. Four surgeons said that they
would use it to replace catgut. Three
other surgeons said that they would
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continue its use only in certain highly
selected instances.
D iscussion

Because earlier studies suggested that
PGA was satisfactory for abdominal
wound closure4*5*7 we used the suture
for other procedures in different parts
of the body to obtain the widest possible
experience and to detect any effect PGA
might have on wound healing.
In those patients in whom it was
used, PGA was used alone so that any
evidence of systemic toxicity might be
clearly recognized.
The overall wound complication rate,
11%, was identical in both experimental
and control groups. No difference was
detected in the complications occurring
in the two groups and the infection rate
was low in both.
Hematomas formed in three of the
PGA wounds and two of the controls.
As might be expected the surgeons
attributed the hematomas in the PGA
group to difficulties in tying the suture.
This appeared to have some validity
because the suture material is inelastic,
does not slip and is unforgiving to the
slip - knot - tying surgeons. However,
there is no problem when a square knot
is laid down properly. The two hema
tomas in the control group weaken this
criticism of PGA. Initially we thought
there were fewer hypertrophic scars in
the PGA group but the final analysis
did not substantiate this. Anscombe,
Hira and Hunt5 found no keloids in 120
wounds sutured with PGA while three
of 82 control wounds developed keloids.
None of the abdominal wounds su
tured with PGA dehisced sufficiently to
require resuturing.
Those surgeons who used this ma
terial concluded that PGA was stronger
and caused less tissue reaction than
catgut. PGA seems to meet the basic
requirements of an ideal suture in that
it is strong, absorbable and does not
iritate the tissues. However, most
surgeons took issue with the handling
qualities of the suture. They felt that
its knot-tying properties were inferior
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to those of catgut. Specifically PGA
dem ands accurate and precise knotty in g as has been comm ented upon by
others.4,5> 7 E a rly in th e study several
surgeons observed th a t PGA produced
more tissue drag. However, w ith g re a t
er experience, seven of the 10 concluded
th a t th e overall handling pro p erties
were acceptable.
This study provides evidence th a t
polyglycolic acid su tu re provides a t
-east as good wound healing as conven
tional su tu re m aterial. Its pro p erties of
strength, absorbability and m inim al
tissue reaction suggest th a t it is su
perio r to catg u t and non-absorbable
sutures. Its only draw back ap p ears to
be its unusual handling qualities neces
sita tin g g re a te r care in knot-tying and
a little patience in its use. W hether th is
defect will p resent an insurm ountable
b a rrie r to th e average surgeon rem ains
to be seen.
Sum m ary
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and m inim al tissue reaction, re p re se n ts
a sig n ific a n t advance over p resen tly
available su tu re m aterial.
W e w ish to th a n k a n d ack n o w led g e th e
c o n s ta n t s u p p o r t a n d g u id a n c e o f D r. R. A .
M acbeth, P ro fe sso r a n d H ead o f th e D e p a r t
m e n t o f S u rg e ry . W e w ould also lik e to th a n k
o u r g e n e ra l su rg ic a l co lleag u es f o r th e ir w ill
in g n e ss to p a rtic ip a te a n d th e o p e ra tin g -ro o m
s t a f f o f th e U n iv e rs ity H o sp ita l f o r th e ir
fo rb e a ra n c e .
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ADVANCES IN SURGERY. Vol. 5. Edited
by Claude E. Welch and James D.
Hardy. 354 pp. Illust. Year Book Medical
Publishers, Inc., Chicago, 1971. $18.50.
Various reviews of diverse topics are in
cluded in this volume.
Parks gives an excellent review of the
anorectal region and a detailed description
of submucous hemorrhoidectomy. Pro
bably of most interest to the average sur
geon is the account of the mechanism
whereby symptoms are produced, as well
as a review of good postoperative care and
the reasons for unsatisfactory results.
The article by Sagel et al. on the newer
radiologic techniques covers a wide
variety of procedures now available for
lesions of the abdomen and chest.
Surgery of the endocrine glands is
well reviewed—insulomas by Nardi, para
thyroid glands by Chiu-an Wang, and the
adrenal glands by Raker. All are excellent.
The biologic principles affecting the
repair of flexor tendons are discussed in a
review article by Weiner and Peacock. The
topic is covered from reaction to injury
to the operative detail in secondary repair.
The present status of tumour immunol
ogy is extremely well presented in a brief
review by Fisher. An excellent bibliogra
phy is attached.
An account of diverticular disease of
the colon is given by Zollinger. Pitfalls in
this disease are well outlined and earlier
surgical correction is recommended. This
seems justified because of the high inci
dence of complications when operation is
deferred until complications have arisen.
Intra-abdominal sepsis is surveyed by
Altemeier, Culbertson and Fullen, the
discussion ranging from primary peri
tonitis to abscesses involving solid organs.
The common bacteria encountered are
noted and the rationale for treatment is
outlined.
W . J. B uie
Division of Surgery,
University of Calgary,
Calgary, Alta.

ANAESTHESIA IN ORGAN TRANS
PLANTATION. Edited by T. Hilary
Howells and Alan W. Grogono. 170 pp.
Illust. S. Karger, Basel; Intercontinen
tal Medical Book Corp., New York, 1972.
$22.50.

To condense a book on anesthesia for
organ transplantation into 160 pages of
text seems impossible. For instance, how
does one deal with the problems associated
with uremia in three-quarters of a page
when we know that volumes have been
written about this subject? Fortunately,
the saving grace of this book is the wellselected references and these would be of
great help both to the anesthetist speci
alizing in this type of work and to the
resident in training who needs as many
references as possible in his pocket.
The book attempts to cover all the prob
lems associated with transplantation of
major organs. A chapter is given to the
clinical evaluation of death, and at the end
of the book there is a section on the immunogenetics of graft rejection. These
two chapters take 50 pages of the original
text. Except for the fact that it is in
teresting reading they are of no true value
to the anesthetist. One wonders if in the
next edition the authors could use this
space to expand on the more important
aspects of organ transplantation.
J. D esm o n d
Department of Anesthesia,
Toronto General Hospital,
Toronto, Ont.

CARE OF THE CRITICALLY ILL CHILD.
R. S. Jones and J. B. Owen-Thomas. 323
pp. Illust. Edward Arnold (Publishers)
Ltd., London; The Macmillan Company
of Canada Limited, Toronto, 1971.
$21.75.
This book attempts to deal with the man
agement of infants and children critically
ill from any cause. It appropriately begins
with a chapter summarizing the general
philosophy of pediatric intensive care.
Physiologic and biochemical mech
anisms of disease are presented in an ex
tensive chapter which includes sections
on circulatory and respiratory physi
ology, the latter so detailed and theoreti
cal as to be understood only by an
esthetists and those specialist pediatrici
ans who treat cases in neonatal intensive
care units. In spite of this criticism this
and the subsequent excellent chapters on
the care of sick neonates, and that on
postoperative cardiac care, make the book
a valuable asset for the libraries of all
(Continued on Adv. p. 33)
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pediatric and neonatal intensive care
units. A later chapter, written by an ex
perienced intensive care nurse, covers
nursing techniques comprehensively and
well but omits the emotional aspects of
intensive care nursing, now recognized as
an interesting and important facet in the
treatment of the critically ill child.
The remainder o f the book consists o f
chapters on serious conditions involving
the other body systems and, in contrast,
deals with them in a rapid and somewhat
cursory fashion. Some of the treatments
recommended are not generally accepted
in North America (e.g. endotracheal in
tubation as treatment for acute epiglot
titis) or are, at best, controversial (e.g.
intrapleural injections o f antibiotics for
staphylococcal empyema). The reader gets
the impression that the authors are
specialists in the handling o f cardio
respiratory problems, especially in the
newborn infant, and lack experience in
other pediatric diseases which can also
make a child critically ill. One notable
omission is a section devoted to the man
agement of the child critically ill from
multiple injuries.

A final chapter deals with some special
ized techniques of treatment such as mech
anical ventilation in infancy, broncho
scopy and tracheostomy, and with electrical
monitoring and is chiefly relevant to in
tensive care units.
Much useful information is available in
the
appendix— nomenclature,
formulas,
normal blood chemistry values, intravenous
therapy, antibiotics and other drugs. This
section is conveniently arranged and the
information is readily available.
This book is well written and a real
contribution to those treating the critically
ill child in specialized hospitals and in
tensive care units. It does not cover in a
consistent and organized way what its title
implies and therefore will be o f little
value to the general pediatrician, phy
sician or surgeon who finds himself treat
ing the critically ill child in emergency
departments and smaller hospitals across
the country.
J. C. F allis
I.O.D.E. Children’s Medical Centre,
North York General Hospital,
Willowdale, Ont.
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EM BRYOLOGY FOR SURGEONS. The
Embryological Basis for the Treatment
of Congenital Defects. Stephen Wood
Gray and John Elias Skandalakis. 918
pp. Illust. W . B. Saunders Company,
Philadelphia; W . B. Saunders Company
Canada Limited, Toronto, 1972. $37.10.

The title of this book clearly emphasizes
its purpose— to make available to surgeons
a well-organized description of normal
fetal evolution and of errors in develop
ment which become manifest in infancy,
childhood and adult life.
Each chapter deals with an organ or
portion of an anatomical system. This sys
tematic approach makes for clarity, and at
the same time the authors have freely
included pertinent details of regional
significance. Sections describing the stages
in development are concise and explicit.
The text is liberally illustrated by good
line drawings, photographs of wax models,
radiographs and clinical photographs. The
process of gradual deviation from the nor
mal development is clearly described for
each anomaly. In each chapter an excellent
table lists the salient features o f each
anomaly in a series of malformations.
Clinical features, differential diagnoses
and classifications are brief but pertinent.
Discussion of surgical treatment is limited

to a statement o f principles involved and
corrective
procedures
generally
used.
Technical descriptions of operations are
excluded except as they relate to ana
tomical and embryologic considerations.
The bibliography at the end o f each
chapter is extensive and correlates well
with the liberal and skilful use o f re
ferences throughout the text. B rief his
torical sections are complementary and
serve to remind us that embryology is a
science of painstaking observation and
deduction.
Surgeons may disagree with certain
points of emphasis in areas of their own
special interest. For instance, the obvious
anatomical and radiologic manifestations
of hiatus hernia here overshadow considera
tion of the symptoms and control o f gastro
esophageal reflux. Also, the clinically in
significant islands o f heterotopic gastric
mucosa in the upper esophagus take undue
precedence over a lower esophagus lined
with gastric mucosa— a condition worthy
of special anatomical and surgical con
sideration.
The volume omits any account of the
embryology and anomalies of the inte
gument, the musculature, face, teeth,
skeletal and nervous systems.

(Continued on Adv. p. 37)
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THE CANADIAN JOURNAL OF SURGERY
All communications concerning this journal
should be marked “’The Canadian Journal of
Surgery” and addressed to the Editor, P.O.
Box 8650, Ottawa, Ontario K1G 0G8.
The Journal is published bi-monthly. Sub
scription is $15 per year ($7.50 per year for
trainees in surgery) and starts with the Janu
ary issue of each year. Single copies are $2.50
each, payable in advance.

IN STR U CTIO N S TO CO NTRIBUTORS
M anuscripts
Manuscripts in duplicate of original articles,
case reports, and other contributions should
be forwarded with a covering letter reauesting consideration for publication in
T h e C anadian Journal o f Surgery. Accept
ance is subject to the understanding that
thev are submitted solely to this Journal,
and will not be reprinted without the con
sent of the author and the publishers. Ac
ceptance or rejection of contributions will
be determined by the Editorial Board. As
space is available, a limited number of case
reports will be published. Articles should
be typed on one side only of unruled paper,
double-spaced, and with wide margins. The
author should always retain a carbon copy
of material submitted. Every article should
contain a summary of the contents. The
Concise Oxford Dictionary will be followed
for spelling. Dorland’s Illustrated Medical
Dictionary will be followed for scientific
terminology. The Editorial Board reserves
the right to make the usual editorial changes
in manuscripts, including such changes as
are necessary to ensure correctness of gram
mar and spelling, clarification of obscurities
or conformity with the style of T he C ana
dian Journal o f Surgery. In no case will
major changes be made without prior con
sultation with the author. Authors will
receive galley proofs of articles before pub
lication and are asked to confine altera
tions of such proofs to a minimum.
Reprints
Beprints may be ordered on a form which
will be supplied with galley proofs. It is
important to order these before publication
of the article, otherwise an extra charge
for additional type-setting will be made.

R eferen ces
References should be referred to by numer
als in the text. They should include in
order: the author’s name and initials in capi
tals, title of the article, abbreviated journal
name, volume number, page number and
year. The abbreviations of journal names
should be those used in Index M edicus.
References to books should include in order:
author’s name and initials, title of book,
number of edition (e.g. second ed.), city
of publication, title of publishing house,
year of publication, page number if a
specific reference. For examples, see this
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white
illustrations will be reproduced free with
the articles. Colour work can be published
only at the author’s expense. Photographs
should be glossy prints, unmounted and
untrimmed, preferably not larger than 8"
x 6". Prints of radiographs are required
and not the originals. The magnification of
photomicrographs must always be given.
Photographs must not be written on or
typed on. An identifying legend may be
attached to the back. Patients must not be
recognizable in illustrations unless the
written consent of the subject for publica
tion has been obtained. Graphs and dia
grams should be drawn in India ink on
suitable white paper. Lettering should be
sufficiently large that after reduction to
fit the size of the Journal page it can still
be read. Legends to all illustrations should
be typed separately from the text and sub
mitted on a separate sheet of paper. Illustra
tions should not be rolled or folded.
Language
It should be clearly understood that con
tributors are at full liberty to submit articles
in either English or French, as they please.
Acceptance will be quite independent of
the language of submission. If the contri
butor wishes, he may submit an informative
summary of not more than 300 words in
the language other than that in which he has
submitted the article. For example, an ar
ticle in English must carry an English sum
mary and may, if the author wishes, carry
a more detailed summary in French.
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The two authors have combined their
very considerable talents for informative,
concise and lucid writing to produce a
text of practical value to both anatomist
and surgeon.
T. K. T h o r l a k so n
Winnipeg Clinic,
Winnipeg, Man.

M AN U AL OF SURGICAL T H E R A P E U 
TICS. 2nd ed. Edited by Robert E. Con
don and Lloyd M. Nyhus. 385 pp. Illust.
Little, Brown and Company, Boston; J.
B. Lippincott Company of Canada Ltd.,
Toronto, 1972. $7.95. Paperbound.

Although this manual is titled “ Surgical
Therapeutics” it also encompasses diag
nosis. Details of operative treatment are
not included.
In outline form, but with adequate
discussion, an abundance of useful in
formation is presented so that the surgical
house officer and student can readily refer
to this source in the daily management of
the problems he will unquestionably en
counter. Pathophysiology is included when
indicated to clarify concepts and pro
cedures.

The chapters cover the evaluation and
management of trauma, shock, cardiac
arrhythmias and arrest, surgical infec
tions, preoperative and postoperative care
with an excellent discussion o f nasogastric,
long intestinal, Sengstaken-Blakemore, com
mon duct and chest tubes (about which
junior surgical house officers frequently
display considerable concern), fluid and
electrolyte therapy, postoperative compli
cations, respiratory and renal insufficien
cy, a complete discussion o f burns, dif
ferential diagnosis of abdominal pain,
massive gastrointestinal hemorrhage, in
testinal obstruction, venous disorders of
the lower extremities, common anorectal
disorders and a final short chapter on
pediatric surgery. Notably absent is a
section on cardiovascular and open heart
surgical problems.
This manual is highly recommended for
fourth-year medical students and house o f
ficers. In addition it provides an up-todate, concise, but all-inclusive review of
value to all surgeons regardless of special
ty.
J. B.

L

it t l e f ie l d

Department of Surgery,
Memorial University of Newfoundland,
St. John’s, Nfld.
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TEXTBOOK OF ELECTROCARDIOGRA
PHY. David Littmann. 553 pp. Illust.
Harper & Row, Publishers, Inc., New
York, 1972. $22.50.
T his is an excellent book w hich fu lfils a
d efin ite need fo r a textbook of electrocar
d iography sh o rter and less detailed than
th e m ore extensive volumes on th e subject,
b u t m ore adequate th an th e b eg in n er’s
m anuals. The book is easy to read and, un
like m ost textbooks on technical m a tte rs, is
m ade in te re stin g to read by the a u th o r’s
lavish use of illustrative tra c in g s of high
quality.
The f ir s t ch ap ter on electrophysiology
and th e norm al ECG is ra th e r superficial
and will not satisfy the m ore in q u irin g
senior stu d en t or house officer b u t will be
adequate fo r anyone w anting a thum b-nail
sketch of th e subject. A slightly m ore com
plete review, w ith more em phasis on the
recent advances in in tracard iac electro
g ram s and H is bundle studies, would make
th e discussion in the succeeding chapters
of clinical abnorm alities related to a rrh y th 
m ias, ju n ctio n al rhythm s, and various
form s of h e a rt block m ore in te re stin g fo r
the non-cardiologist read er who is not
fa m iliar w ith th e recent lite ra tu re in th is
area. The fin al chapter dealing w ith the
m ethod of approach to th e unknow n ECG is
especially relevant in allow ing th e read er to
p u t into p roper perspective w h at he has
learned from the book.
The b ib lio g rap h y is a d e q u a te b u t ten d s
to cover the classical papers on th e various
d isorders a t th e expense of the m ost recent
review s. This, however, is a m inor fa u lt in
a book of th is nature.
In essence, Dr. L ittm an n ’s book is to be
highly recommended fo r senior medical
stu d ents and all levels of house officer. It
will be m ost useful to th e non-cardiologist
clinician who requires a com prehensive but
easily readable textbook on electrocardio
graphy. The high quality of the illu strativ e
tra c in g s and the clear descriptions below
them add to th e clarity of the text.
Paul H. T anser
D epartm ent of Cardiology,
Royal V ictoria Hospital,
M ontreal, Que.

TRANSPLANTATION GENETICS OF
PRIMATES. Edited by Hans Balner and
Jon J. van Rood. 152 pp. Illust. Grune
& Stratton, Inc., New York; Longman
Canada Limited, Toronto, 1972. $14.70.
T his m onograph contains the published
proceedings of the F ir s t In tern atio n al
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Histocompatibility Workshop and Sympo
sium on Primates held in September 1971
in Rijswijk, The Netherlands. The text as
sembles a large volume of interesting data
and the overall clarity is enhanced by the
joint report of the Workshop. This report,
forming the last chapter in the book, con
tains the analyses of the Workshop data and
the conclusions reached during the discus
sion of results. A total of 202 primates were
typed: 60 chimpanzees and 142 rhesus
monkeys (87 unrelated, and 55 children of
the families). The typing results were an
alyzed by sophisticated computer programs.
RhL-A system was recognized as the major
histocompatibility system of rhesus mon
keys. Following the procedure used at the
Fourth International Histocompatibility
Workshop on Humans in 1970 the antigenic
groups were divided into RhL-A and RhW
(Workshop) designations, to which were as
signed three and eight specificities respect
ively. For chimpanzees, only ChW designa
tions were assigned, since no family data
were available. The groups of antisera de
fining chimpanzee specificities shown to be
the unequivocal analogues of human anti
gens were given HL-A-related designations,
e.g. ChW4 for 4a, ChW6 for 4b, and C hW ll
for HL-A11. ChW groups not related to
known HL-A specificities were assigned
sequence numbers above 100.
The main text of the book comprises pa
pers presented by various investigators at
the symposium. It is confusing, at least in
the beginning, since each investigator uses
his own nomenclature. However, the data
presented are interesting and stimulating.
The experience gained in the field of human
leukocyte antigens afforded a tremendous
advantage in studying serology, genetics
and chemistry of antigens of primates. The
similarity between the role of RhL-A for
histocompatibility in monkeys and the role
of HL-A in human transplantations is evi
dent from the data presented by Balner et
al. Using human leukoagglutinating sera to
study leukocyte groups of baboons, Down
ing et al. observed that baboons have a
leukocyte antigen that resembles HL-A7 in
humans. A number of papers discuss the
similarities, differences and cross-reactions
between HL-A and ChL-A. This will be an
indispensable reference book for any person
interested in leukocyte antigens of pri
mates.
D.

P. SlNGAL

Department of Pathology,
McMaster University Medical Center,
Hamilton, Ont.
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